Hong Kong Exchanges and Clearing : BLUE APPLICATION FORM

September 11, 2019 at 06:57 pm EDT

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

Please staple your payment here

請將股款

緊釘在此

This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019（the "Prospectus"）.

本申請表格使用上海復宏漢霖生物技術股份有限公司（「本公司」）於二零一九年九月十二日刊發的招股章程（「招股章程」）所界定的相同詞彙。

Neither this Application Form nor the Prospectus constitutes an offer to sell or the solicitation of an offer to buy any Hong Kong Offer Shares in any jurisdiction other than Hong Kong. The Hong Kong Offer Shares may not be offered or sold in the United States without registration or an exemption from registration under the U.S. Securities Act.

本申請表格及招股章程概不構成在香港以外任何司法權區要約出售或游說要約購買任何香港發售股份。若無根據美國證券法登記或豁免登記，香港發售股份不得在美國提呈發售或出售。

This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in any
	版
manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under the law of
that jurisdiction.

任何根據當地法例不得發送、派發或轉載本申請表格及招股章程的司法權區內概不得發送或派發或轉載（不論方式，亦不論全部或部分）本申請表格及招股章程。

Copies of the Prospectus, all related Application Forms and the other documents specified in the "Documents Delivered to the Registrar of Companies in Hong Kong and Available for Inspection - Documents Delivered to the Registrar of Companies" section in Appendix VII to the Prospectus, have been registered by the Registrar of Companies in Hong Kong as required by section 342C of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Chapter 32 of the Laws of Hong Kong). Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the "Stock Exchange"), Hong Kong Securities Clearing Company Limited ("HKSCC"), the Securities and Futures Commission of Hong Kong (the "SFC") and the Registrar of Companies of Hong Kong take no responsibility for the contents of these documents.

招股章程、所有相關申請表格及招股章程附錄七「送呈香港公司註冊處處長及備查文件－送呈公司註冊處處長文件」一節所述的其他文件均已根據香港法例第32 章《公司（清盤及雜項條文）條例》第342C 條規定送呈香港公司註冊處處長辦理登記。香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）、香港中央結算有限公司（「香港結算」）、香港證券及期貨事務監察委員會（「證監會」）及香港公司註冊處處長對此等文件的內容概不負責。

Shanghai H nlius Biot ch, Inc.

上海復宏漢霖生物技術股份有限公司

(A joint stock company incorporated in the P op 's R public of China with limited liability)
（於中華人民共和國註冊成立的股份有限公司）
Stock code	:	2696樣
股份代號 :	2696
Maximum Offer Price	:	HK$57.80 per Offer Share, plus brokerage fee of
		1%, SFC transaction levy of 0.0027% and Stock
		Exchange trading fee of 0.005% (payable in full
		on application in Hong Kong dollars, subject to
		refund)
最高發售價：每股發售股份57.80 港元，另加1% 經紀佣金、
		0.0027% 證監會交易徵費及0.005% 聯交所交
		易費（須於申請時以港元繳足，多繳款項可予退
		還）
Applic nts' decl r tion		申請人聲明
I/We agree to the terms nd conditions and application		本人╱吾等同意本申請表格及招股章程的條款及
procedures in this Application Form and the		條件以及申請程序。請參閱本申請表格「丁. 填交
Prospectus. Please refer to the "D. Effect of completing		本申請表格的效用」一節。
and submitting this Application Form" section of this
Application Form.
Warning:SampleOnly one application may be made for the 警告：任何人士僅可為本身利益以藍色申請表格
benefit of any person for Reserved Shares on a BLUE		就預留股份作出一次申請。下列情況將不獲受
Application Form. The following are liable to be		理：就預留股份作出的重複或疑屬重複申請以及
rejected: multiple or suspected multiple applications		支票或銀行本票在首次過戶時未能兌現的申請。
for Reserved Shares and applications where cheques or
banker's cashier orders are dishonoured upon the first
presentation.

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）
Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and
have difficulties applying online via www.eipo.com.hk
閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格
Name(s) and address of the Qualifying Fosun Pharma H Shareholder	User ID 使用者編號
合資格復星醫藥H 股股東姓名╱名稱及地址

Access Code 通行編號

																				CCS6535								版


	Apply for Assured Entitlement of Reserved Shares									Box A
										Number of Fosun Pharma H Shares registered in your
	You may apply for a number of Reserved Shares pursuant to your Assured Entitlement that is equal to or less than the number stated	甲欄		name as at 4:30 p.m. on Wednesday, 4 September 2019
	in Box B. If you intend to apply for a number of Reserved Shares that is less than your Assured Entitlement, you MUST apply for a		(the "Record Date"):
	number which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number				於二零一九年九月四日（星期三）（「記錄日期」）下午四時
	of Assured Entitlement which is not one of the numbers set out in the table below, you MUST apply by using Blue Form eIPO				三十分以閣下名義登記之復星醫藥H 股數目：
	only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the

	BLUE Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on	Box B		Number of Reserved Shares in your Assured Entitlement:		Amount payable if your Assured Entitlement is taken up
	application in respect of the excess Reserved Shares applied for or apply through the Blue Form eIPO service via www.eipo.com.hk.	乙欄		閣下所獲保證配額之預留股份數目：								in full:
	You need to complete and sign this Application Form and submit one cheque (or banker's cashier order) for the exact amount of														閣下保證配額獲全數接納應付款項：
	remittance printed in Box B on the right or in the table below.												樣					HK$ 港元
	申請保證配額之預留股份
	閣下申請保證配額之預留股份數目可相等於或少於乙欄列明的數目。倘閣下擬申請的預留股份數目少於閣下的保
	證配額，閣下必須申請下表中載列的其中一個數目（香港結算代理人除外）。倘閣下擬申請不在下表中載列的其中
	一個保證配額數目，閣下必須用藍表eIPO 申請。倘	閣下擬申請保證配額以外的超額預留股份，則須填妥並簽署申
	請超額預留股份之藍色申請表格，並單獨匯款足額支付所申請超額預留股份的應付股款，或透過www.eipo.com.hk使
	用藍表eIPO 服務遞交申請。
	閣下須填妥及簽署本申請表格並提交一張支票（或銀行本票）支付於右方乙欄或下表列明的應付確切金額。



														NUMBER OF RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
																	可供申請認購的預留股份數目及款項
									Amount payable					Amount payable					Amount payable												Amount payable
			No. of Reserved		on application					No. of Reserved	on application			No. of Reserved		on application						No. of Reserved			on application
		Shares applied for			HK$					Shares applied for	HK$			Shares applied for		HK$								Shares applied for				HK$
			申請認購的預留		申請時應繳款項			申請認購的預留	申請時應繳款項			申請認購的預留		申請時應繳款項					申請認購的預留			申請時應繳款項
			股份數目			（港元）					股份數目	（港元）			股份數目			（港元）						股份數目			（港元）
	100		5,838.25				2,500	145,956.13			30,000	1,751,473.52						600,000		35,029,470.36
	200		11,676.49				3,000	175,147.35			40,000	2,335,298.02						700,000		40,867,715.42
	300		17,514.74				3,500	204,338.58			50,000	2,919,122.53						800,000		46,705,960.48
	400		23,352.98				4,000	233,529.80			60,000	3,502,947.04						900,000		52,544,205.54
	500		29,191.23				4,500	262,721.03			70,000	4,086,771.54						1,000,000		58,382,450.60
	600		35,029.47				5,000	291,912.25			80,000	4,670,596.05						1,500,000		87,573,675.90
	700		40,867.71				6,000	350,294.70			90,000	5,254,420.55						2,000,000		116,764,901.20
	800		46,705.96				7,000	408,677.15			100,000	5,838,245.06						2,500,000		145,956,126.50
	900		52,544.20				8,000	467,059.60			200,000	11,676,490.12						3,000,000		175,147,351.80
	1,000		58,382.45				9,000	525,442.06			300,000	17,514,735.18						3,500,000		204,338,577.10
	1,500		87,573.68				10,000	583,824.51			400,000	23,352,980.24						4,000,000		233,529,802.40
	2,000		116,764.90				20,000	1,167,649.01			500,000	29,191,225.30						4,186,000		244,388,938.21

Write down the number of Reserved Shares you want to a ly for and the total amount	ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath.
請在以下適當空格內用墨水筆（以黑色為佳）填寫	閣下擬申請之預留股份數目及應繳總額，並在相應空格內加上「X」。

			Number of Assured Entitlement applied for								Total amount of remittance (HK$)
			申請保證配額數目																	付款總額（港元）
								,				,														,						,				,				.
				,

	0	0	,	0	0	0	,	0	0	0	,	0	0	0							0	0	0	,		0	0	0	,	0	0	0	,	0	0	0	.	0	0

	1	1	,	1	1	1	,	1	1	1	,	1	1	1							1	1	1	,		1	1	1	,	1	1	1	,	1	1	1	.	1	1

	2	2	,	2	2	2	,	2	2	2	,	2	2	2							2	2	2	,		2	2	2	,	2	2	2	,	2	2	2	.	2	2

	3	3	,	3	3	3	,	3	3	3	,	3	3	3							3	3	3	,		3	3	3	,	3	3	3	,	3	3	3	.	3	3

	4	4	,	4	4	4	,	4	4	4	,	4	4	4							4	4	4	,		4	4	4	,	4	4	4	,	4	4	4	.	4	4

	5	5	,	5	5	5	,	5	5	5	,	5	5	5							5	5	5	,		5	5	5	,	5	5	5	,	5	5	5	.	5	5

	6	6	,	6	6	6	,	6	6	6	,	6	6	6							6	6	6	,		6	6	6	,	6	6	6	,	6	6	6	.	6	6

	7	7	,	7	7	7	,	7	7	7	,	7	7	7							7	7	7	,		7	7	7	,	7	7	7	,	7	7	7	.	7	7

	8	8	,	8	8	8	,	8	8	8	,	8	8	8							8	8	8	,		8	8	8	,	8	8	8	,	8	8	8	.	8	8

	9	9	,	9	9	9	,	9	9	9	,	9	9	9							9	9	9	,		9	9	9	,	9	9	9	,	9	9	9	.	9	9

You must pay for the Reserved Shares applied for pursuant to your Assured Entitlement by a separate cheque or banker's cashier order.
閣下必須以獨立開出的支票或銀行本票支付根據	閣下的保證配額所申請的預留股份。

* Cheque or banker's cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The
applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order.
* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出，並須註明抬頭人為「中國銀行Sample( 香港) 代理人有限公司－復宏漢霖生物技術優先發售」。申請人名稱╱聯名申請的排名首位申請人名稱須與在支票╱銀行本
票的預印名稱或由銀行授權人士在支票╱銀行本票背書的名稱相同。
Cheque/Banker's cashier order number*	Signed by (all) applicant(s) (all joint applicants must sign):
支票╱銀行本票號碼*		由（所有）申請人簽署（所有聯名申請人必須簽署）：
Name of bank on which cheque/banker's

cashier order is drawn*
支票╱銀行本票之付款銀行名稱*
Contact telephone no.
聯絡電話號碼

You (or if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/
passport number/Hong Kong business registration certificate number (Please delete as appropriate)
閣下或（倘閣下為聯名申請人）排名首位申請人必須提供香港身份證號碼╱護照號碼╱香港商業登記	Date 日期：
號碼（請刪除不適用者）	................................... /................................... /...................................
			D 日	M 月	Y 年

Excess	請
Application
	申
額
超

BLUE FORM 藍表（Excess Application 超額申請）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

Please staple your payment here

請將股款

緊釘在此

This Application Form uses the same terms as defined in the prospectus of Shanghai Henlius Biotech, Inc. (the "Company") dated 12 September 2019 (the "Prospectus").

本申請表格使用上海復宏漢霖生物技術股份有限公司（「本公司」）於二零一九年九月十二日刊發的招股章程（「招股章程」）所界定的相同詞彙。

This Application Form and the Prospectus may not be forwarded or distributed or reproduced (in whole or in part) in
	版
any manner whatsoever in any jurisdiction where such forwarding, distribution or reproduction is not permitted under
the law of that jurisdiction.

Shanghai H nlius Biot ch, Inc.

上海復宏漢霖生物技術股份有限公司

(A joint stock company incorporated in the P	op 's R public of China with limited liability)
（於中華人民共和國註冊成立的股份有限公司）
Stock code	:	樣
2696
股份代號 :	2696
Maximum Offer Price	:	HK$57.80 per Offer Share, plus brokerage fee of
		1%, SFC transaction levy of 0.0027% and Stock
		Exchange trading fee of 0.005% (payable in full
		on application in Hong Kong dollars, subject to
		refund)
最高發售價：每股發售股份57.80 港元，另加1% 經紀佣金、
		0.0027% 證監會交易徵費及0.005% 聯交所交
		易費（須於申請時以港元繳足，多繳款項可予退
		還）
Applic nts' decl r tion		申請人聲明
I/We agree to the terms nd conditions and application		本人╱吾等同意本申請表格及招股章程的條款及
procedures in this Application Form and the		條件以及申請程序。請參閱本申請表格「丁. 填交
Prospectus. Please refer to the "D. Effect of completing		本申請表格的效用」一節。
and submitting this Application Form" section of this
Application Form.
Sample
Warning: Only one application may be made for the		警告：任何人士僅可為本身利益以藍色申請表格
benefit of any person for excess Reserved Shares on a		就超額預留股份作出一次申請。下列情況將不獲
BLUE Application Form. The following are liable to be		受理：就超額預留股份作出的重複或疑屬重複申
rejected: multiple or suspected multiple applications for		請以及支票或銀行本票在首次過戶時未能兌現的
excess Reserved Shares and applications where cheques		申請。
or banker's cashier orders are dishonoured upon the
first presentation.

Name(s) and address of the Qualifying Fosun Pharma H Shareholder 合資格復星醫藥H 股股東姓名╱名稱及地址

Excess	請
Application
	申
額
超

BLUE FORM 藍表（Excess Application 超額申請）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

User ID 使用者編號

Access Code 通行編號

CCS6535

Apply for Excess Reserved Shares

Other than your Assured Entitlement, you may apply for excess Reserved Shares. If you intend to apply for excess Reserved Shares, you MUST apply for a number of excess Reserved Shares which is one of the numbers set out in the table below (other than HKSCC Nominees). If you intend to apply for a number of excess Reserved Shares which is not one of the numbers set out in the table below, you MUST apply by using Blue Form eIPO only. If you wish to apply for excess Reserved Shares in addition to your Assured Entitlement, you should complete and sign the BLUE Application Form for excess Reserved Shares and lodge it, together with a separate remittance for the full amount payable on application in respect of the excess Reserved Shares applied for or apply through the Blue Form eIPO service via www.eipo.com.hk.

You need to complete and sign this Application Form and submit one cheque (or banker' s cashier order) for the exact amount of remittance in the table below.

申請超額預留股份

除保證配額外，閣下亦可申請超額預留股份。倘閣下擬申請超額預留股份，閣下必須申請下表中載列的其中一個超額預留股份數目（香港結算代理人除外）。倘閣下擬申請不在下表中載列的其中一個超額預留股份數目，閣下必須用藍表eIPO 申請。倘閣下擬申請保證配額以外的超額預留股份，則須填妥並簽署申請超額預留股份之藍色申請表格，並單獨匯款足額支付所申請超額預留股份的應付股款，或透過www.eipo.com.hk使用藍表eIPO 服務遞交申請。閣下須填妥及簽署本申請表格並提交一張支票（或銀行本票）支付下表中載列的應付確切金額。

												NUMBER OF EXCESS RESERVED SHARES THAT MAY BE APPLIED FOR AND PAYMENTS
																		可供申請認購的超額預留股份數目及款項
									Amount payable					Amount payable					Amount payable										Amount payable
		No. of Reserved			on application			No. of Reserved	on application	No. of Reserved				on application			版
													No. of Reserved				on application
	Shares applied for				HK$			Shares applied for	HK$	Shares applied for					HK$						Shares applied for					HK$
		申請認購的預留			申請時應繳款項			申請認購的預留	申請時應繳款項	申請認購的預留			申請時應繳款項					申請認購的預留			申請時應繳款項
		股份數目				（港元）			股份數目	（港元）	股份數目				（港元）						股份數目					（港元）
			100				5,838.25				2,500	145,956.13		30,000			1,751,473.52						600,000			35,029,470.36
			200				11,676.49				3,000	175,147.35		40,000			2,335,298.02						700,000			40,867,715.42
			300				17,514.74				3,500	204,338.58		50,000			2,919,122.53						800,000			46,705,960.48
			400				23,352.98				4,000	233,529.80		60,000			3,502,947.04						900,000			52,544,205.54
			500				29,191.23				4,500	262,721.03		70,000			4,086,771.54						1,000,000			58,382,450.60
			600				35,029.47				5,000	291,912.25		80,000			4,670,596.05						1,500,000			87,573,675.90
			700				40,867.71				6,000	350,294.70		90,000			5,254,420.55						2,000,000			116,764,901.20
			800				46,705.96				7,000	408,677.15	100,000			5,838,245.06						2,500,000			145,956,126.50
			900				52,544.20				8,000	467,059.60	200,000			11,676,490.12						3,000,000			175,147,351.80
			1,000				58,382.45				9,000	525,442.06	樣						3,500,000			204,338,577.10
									300,000			17,514,735.18
			1,500				87,573.68				10,000	583,824.51	400,000			23,352,980.24						4,000,000			233,529,802.40
			2,000				116,764.90				20,000	1,167,649.01	500,000			29,191,225.30						4,186,000			244,388,938.21

Sample
Write down the number of excess Reserved Shares you want to a ly for and the total amount ayable in the following appropriate boxes in ink (preferably in black) and mark "X" in the corresponding boxes underneath.
請在以下適當空格內用墨水筆（以黑色為佳）填寫	閣下擬申請之超額預留股份數目及應繳總額，並在相應空格內加上「X」。
		Number of excess Reserved Shares applied for					Total amount of remittance (HK$)
		申請超額預留股份數目														付款總額（港元）
			,				,					,												,					,					,					.
0		0	,	0	0	0	,	0	0	0	,	0	0	0					0	0	0		,	0	0	0	,	0	0	0	,	0	0		0	.	0	0
1		1	,	1	1	1	,	1	1	1	,	1	1	1					1	1	1		,	1	1	1	,	1	1	1	,	1	1		1	.	1	1
2		2	,	2	2	2	,	2	2	2	,	2	2	2					2	2	2		,	2	2	2	,	2	2	2	,	2	2		2	.	2	2
3		3	,	3	3	3	,	3	3	3	,	3	3	3					3	3	3		,	3	3	3	,	3	3	3	,	3	3		3	.	3	3
4		4	,	4	4	4	,	4	4	4	,	4	4	4					4	4	4		,	4	4	4	,	4	4	4	,	4	4		4	.	4	4

5		5	,	5	5	5	,	5	5	5	,	5	5	5					5	5	5		,	5	5	5	,	5	5	5	,	5	5		5	.	5	5

6		6	,	6	6	6	,	6	6	6	,	6	6	6					6	6	6		,	6	6	6	,	6	6	6	,	6	6		6	.	6	6

7		7	,	7	7	7	,	7	7	7	,	7	7	7					7	7	7		,	7	7	7	,	7	7	7	,	7	7		7	.	7	7

8		8	,	8	8	8	,	8	8	8	,	8	8	8					8	8	8		,	8	8	8	,	8	8	8	,	8	8		8	.	8	8

9		9	,	9	9	9	,	9	9	9	,	9	9	9					9	9	9		,	9	9	9	,	9	9	9	,	9	9		9	.	9	9

You must pay for the excess Reserved Shares applied for by a separate cheque or banker's cashier order. 閣下必須以獨立開出的支票或銀行本票支付所申請的超額預留股份。

* Cheque or banker' s cashier order should be crossed "Account Payee Only" and made payable to "BANK OF CHINA (HONG KONG) NOMINEES LIMITED - HENLIUS BIOTECH PREFERENTIAL OFFER". The applicant's name/the first applicant's name on the joint application must be the same as the name pre-printed or certified/endorsed by a person authorised by the drawee bank on the cheque/banker's cashier order.


* 支票或銀行本票須以「只准入抬頭人賬戶」方式劃線開出，並須註明抬頭人為「中國銀行( 香港) 代理人有限公司－復宏漢霖生物技術優先發售」。申請人名稱╱聯名申請的排名首位申請人名稱須與在支票╱銀行本
票的預印名稱或由銀行授權人士在支票╱銀行本票背書的名稱相同。
Cheque/Banker's cashier order number*	Signed by (all) applicant(s) (all joint applicants must sign):
支票╱銀行本票號碼*		由（所有）申請人簽署（所有聯名申請人必須簽署）：
Name of bank on which cheque/banker's

cashier order is drawn*
支票╱銀行本票之付款銀行名稱*
Contact telephone no.
聯絡電話號碼
You (or, if you are joint applicants, the first-named applicant) must provide your Hong Kong identity card number/
passport number/Hong Kong business registration certificate number (Please delete as appropriate)
閣下或（倘閣下為聯名申請人）排名首位申請人必須提供香港身份證號碼╱護照號碼╱香港商業登記
號碼（請刪除不適用者）		Date 日期：	................................... /................................... /...................................

D 日

M 月

Y 年

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

Application Form for Assured Entitlement of Qualifying Fosun Pharma H Shareholders

合資格復星醫藥 H 股股東保證配額申請表格

For Qualifying Fosun Pharma H Shareholders,				合資格復星醫藥H 股股東的
applications will be accepted until 12:00 noon				截止接受申請時間
on Tuesday, 17 September 2019.					為二零一九年九月十七日
You must read the conditions and instructions				（星期二）中午十二時正。
attached to this Application Form.				閣下務必細閱本申請表格隨附的
To be valid, you must complete all applicable parts				條件及指示。
	of this Application Form.			本申請表格各適用部分必須以英文用墨水筆或
Please write clearly in English and in ink.			原子筆清楚填妥，方為有效。

Mixed Media Offer				混合媒介要約
The Company will be relying on Section 9A of the Companies		本公司將依據香港法例第32L 章《公司（豁免公司及招股
(Exemption of Companies and Prospectuses from Compliance		章程遵從條文）公告》第9A 條，在(i) 並非與招股章程印
with Provisions) Notice (Chapter 32L of the Laws of Hong		刷本一併發出的情況下，發出白色及黃色申請表格；及
Kong) and will be issuing the (i) WHITE and YELLOW		(ii) 並非與招股章程印刷本一併發出的情況下，向相關
Application Forms without them being accompanied by a		合資格復星國際股東發出橙色申請表格及向相關合資格
printed Prospectus; and (ii) the ORANGE Application Forms		復星醫藥H 股股東發出藍色申請表格，除非相關合資格
to the relevant Qualifying Fosun International Shareholders and		復星國際股東或相關合資格復星醫藥H 股股東（視情況
the BLUE Application Forms to the relevant Qualifying Fosun		而定）已選擇根據復星國際或復星醫藥（視情況而定）公
Pharma H Shareholders without them being accompanied by		司通訊政策收取公司通訊印刷本或未被要求選擇收取復
a printed Prospectus, unless the relevant Qualifying Fosun					版
	星國際或復星醫藥（視情況而定）公司通訊稿的方式，在
International Shareholders or the relevant Qualifying Fosun		此情況下，招股章程印刷本會分開寄發予彼等。招股章
Pharma H Shareholders (as the case may be) have el ct d to		程的印刷本的內容與招股章程的電子版本相同，招股章
receive corporate communications in printed form und r the		程的電子版本分別在本公司網站www.henlius.com及聯
corporate communications policy of Fosun International or		交所網站www.hkexnews.hk「披露易＞上市公司公告＞
Fosun Pharma (as the case may be), or have not been ask d to		最新上市公司公告」一欄中可供查閱及下載。
elect the means of receiving the corporate communications of		樣
Fosun International or Fosun Pharma (as the case may b ), in
which case the printed Prospectus will be des atched to them

separately. The contents of the printed Pros ectus are identical
to the electronic version of the Pros ectus which can be
accessed and downloaded from the websites of the Com any at
www.henlius.comand the Stock Exchange at www.hkexnews.
hkunder the "HKExnews > Listed Com any Information >
Latest Listed Company Infor ation " section, respectively.
Members of the public, the Qualifying Fosun International		有意索取招股章程印刷本的公眾人士、合資格復星國
Shareholders and the Qualifying Fosun Phar a H Shareholders		際股東及合資格復星醫藥H 股股東可於二零一九年九月
who wish to obt in copy of the printed Prospectus	ay obtain		十二日（星期四）上午九時正至二零一九年九月十七日
a copy, free of ch rge, upon request during nor	al business		（星期二）中午十二時正的正常辦公時間內，在以下地點
hours from 9:00	. . on Thursd y, 12 Septe ber 2019 until		免費索取：
12:00 noon on Tuesd y, 17 September 2019 at the following
locations:
1. any of the following br nches of the receiving banks of the		1. 本公司收款銀行的下列任何分行：
Company:
Bank of China (Hong Kong) Limited			中國銀行（香港）有限公司
District	Branch Name	Address			地區		分行名稱		地址
Hong Kong Island	Des Voeux Road	111-119 Des Voeux Road West,		香港島		德輔道西分行	香港德輔道西
	West Branch	Hong Kong							111-119號
SampleChai Wan Branch Block B, Walton Estate,				柴灣分行		香港
		341-343 Chai Wan Road,						柴灣道341-343號
		Chai Wan,							宏德居B座
		Hong Kong
Kowloon	Telford Plaza Branch	Shop Unit P2-P7,		九龍		德福廣場分行	九龍灣
		Telford Plaza,							偉業街33號
		No.33 Wai Yip Street,						德福廣場
		Kowloon Bay,							P2-P7號舖
		Kowloon

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

	Olympian City Branch	Shop 133, 1/F,			奧海城分行		九龍
		Olympian City 2,					海庭道18號
		18 Hoi Ting Road,					奧海城二期
		Kowloon					一樓133號
New Territories	Metro City Branch	Shop 209, Level 2,		新界	新都城分行		新界
		Metro City Phase 1,					將軍澳
		Tseung Kwan O,					新都城一期
						版
		New Territories					二樓209號
	Ma On Shan Plaza	Shop 2103, Level 2,			馬鞍山廣場分行	新界
	Branch	Ma On Shan Plaza,					馬鞍山
		Sai Sha Road,					西沙路
		Ma On Shan,					馬鞍山廣場
		New Territories					L2層2103號
CMB Wing Lung Bank Limited			招商永隆銀行有限公司
				樣		地址
District	Branch Name	Address		地區	分行名稱
Hong Kong Island	Head Office	45 Des Voeux Road Central		香港島	總行		德輔道中45號
	Kennedy Town Branch	28 Catchick Street			堅尼地城分行	吉席街28號
Kowloon	Mongkok Branch	B/F CMB		九龍	旺角分行		彌敦道636號
		Wing Lung Bank Centre,					招商永隆
		636 Nathan Road					銀行中心地庫
	Tsim Sha Tsui Branch	4 Carnarvon Road			尖沙咀分行		加拿分道4號
Sample		新界	荃灣分行		沙咀道251號
New Territories	Tsuen Wan Branch	251 Sha Tsui Road
2. any of the following offices of	the below Joint G obal		2. 以下聯席全球協調人的下列任何辦事處：
Coordinators:
China International Capital Corporation Hong Kong		中國國際金融香港證券有限公司
Securities Limited			香港
29th Floor, One International Finance Centre		中環
1 Harbour View Street			港景街1 號
Central				國際金融中心一期29 樓
Hong Kong
Merrill Lynch (Asia Pacific) Limited		Merrill Lynch (Asia Pacific) Limited
Level 55 Cheung Kong Center			香港
2 Queen's Road Central			中環
Central				皇后大道中2 號
Hong Kong				長江集團中心55 樓
BOCI Asia Li	ited			中銀國際亞洲有限公司
26th Floor, B nk of China Tower			香港
1 G rden Ro d				中環
Centr l				花園道1 號
Hong Kong				中銀大廈26 樓
UBS AG Hong Kong Br nch			UBS AG Hong Kong Branch
52/F, Two International Finance Centre		香港
8 Finance treet				中環
Central				金融街8 號
Hong Kong				國際金融中心二期52 樓
CMB International Capital Limited		招銀國際融資有限公司
45/F, Champion Tower			香港
3 Garden Road				中環
Central				花園道3 號
Hong Kong				冠君大廈45 樓
Fosun Hani Securities Limited			復星恆利證券有限公司
Suite 2101-2105 21/F Champion Tower		香港
3 Garden Road				中環
Central				花園道3 號
Hong Kong				冠君大廈21 樓2101-2105室

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

3. the Depository Counter of HKSCC at 1/F, One & Two Exchange		3. 香港結算存管處服務櫃檯，地址為香港中環康樂廣
Square, 8 Connaught Place, Central, Hong Kong.			場8 號交易廣場一座及二座一樓。
Details of where printed Prospectuses may be obtained		可索取招股章程印刷本的地址詳情將於派發白色申請表
will be displayed prominently at every designated branch		格的收款銀行各指定分行以顯眼方式展示。
of receiving banks where WHITE Application Forms are
distributed.
During normal business hours from 9:00 a.m. on Thursday, 12		於二零一九年九月十二日（星期四）上午九時正至二零
					版
September 2019 until 12:00 noon on Tuesday, 17 September		一九年九月十七日（星期二）中午十二時正的正常辦公時
2019, at least three copies of the printed Prospectus will be		間內，在派發白色及黃色申請表格的各個地點（載於招
available for inspection at every location where the WHITE		股章程「如何申請香港發售股份及預留股份」），均有至
and YELLOW Application Forms are distributed as set out in		少三份招股章程印刷本可供查閱。
the section headed "How to Apply for Hong Kong Offer Shares
and Reserved Shares" in the Prospectus.
To: Shanghai Henlius Biotech, Inc.			致：上海復宏漢霖生物技術股份有限公司
				樣
Joint Sponsors				聯席保薦人
Joint Global Coordinators			聯席全球協調人
Joint Representatives				聯席代表
Joint Bookrunners				聯席賬簿管理人
Hong Kong Underwriters				香港包銷商
Sample
I/We:				本人╱我們：
‧ being the Qualifying Fosun Pharma H Shareholder(s) nam d		‧ 乃名列本申請表格之合資格復星醫藥H 股股東，按照招
on this Application Form, apply for the number of R s rv d		股章程及本申請表格所載條款及條件以及在貴公司章
Shares specified or deemed to be specified, on the t rms and		程細則規限下，申請所指定或視作指定數目之預留股
conditions of the Prospectus and this Application Form, and		份；
subject to the Articles of Association of the Company;
‧ enclose payment in full for the Reserved Shares app i d for		‧ 隨附以最高發售價每股發售股份57.80 港元（多繳款項可
at the Maximum Offer Price of HK$57.80 er Off r Share		予退還）計算申請認購預留股份所需的全數付款（包括
(subject to refund), including a 1% brokerage fee, a 0.0027%		1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯交
SFC transaction levy and a 0.005% Stock Exchange trading		所交易費）；
fee;
‧ undertake and agree to accept the Reserved Shares a lied		‧ 承諾及同意接納本人╱我們就本申請所申請認購的預留
for, or any lesser number allotted to me/us on this a	lication;		股份，或獲配發的任何較少數目；
‧ warrant that this is the	only a lication ade	by me/us		‧ 保證是項申請乃本人╱我們就預留股份為本人╱我們本
for Reserved Shares for	y/our own benefit (other than an		身利益作出之唯一申請（除以合資格復星國際股東身份
application (if any) ade in the capacity as a Qualifying Fosun		作出的申請（如有）外）；
International Shareholder);
‧ underst nd nd confirm th t these declarations and		‧ 明白及確認	貴公司及聯席代表將依賴該等聲明及陳
represent tions will be relied upon by the Co pany and the		述，以決定是否就本申請向本人╱我們配發任何預留股
Joint Represent tives in deciding whether or not to	ake any		份，而本人╱我們如果作出虛假聲明可能會被檢椌；
allotment of Reserved Sh res to me/ us in response to this
applic tion nd th t I/we m y be prosecuted for making a false
declar tion;
‧ authorise the Company to place my/our name(s) on the H		‧ 授權貴公司將本人╱我們的姓名╱名稱列入H 股股東
hare register as the holder(s) of any Reserved Shares to be		名冊內，作為將配發予本人╱我們的任何預留股份的持
allotted to me/us and such other registers as required under		有人，及根據	貴公司章程細則規定的其他登記冊內，
the Articles of Association of the Company, and despatch		並按本申請表格上所示地址以普通郵遞方式向本人╱
any hare certificate(s) (where applicable) and/or any refund		我們寄發任何股票（如適用）及╱或任何退款支票（如適
cheque(s) (where applicable) to me/us by ordinary post at my/		用），郵誤風險概由本人╱我們自行承擔（除非本人╱我
our own risk to the address stated in this Application Form		們申請1,000,000 股或以上預留股份，且本人╱我們符
unless I/ we have applied for 1,000,000 Reserved Shares or		合資格按本申請表格規定親自領取任何股票及╱或任何
more and I/we am/are eligible to collect any Share certificate(s)		退款支票（如適用））；

and/or any refund cheque (where applicable) personally, as provided in this Application Form;

undertake to sign all documents and to do all things necessary to enable me/us to be registered as the holder of the Reserved Shares to be allocated to me/us, and as required by the Articles of Association of the Company;

‧ 承諾簽署所有文件並採取所有必要的事宜，以及根據貴公司章程細則規定讓本人╱我們登記為本人╱我們獲分配的預留股份的持有人；

AssuredEntitlement配額

保證

BLUE FORM 藍表（Assured Entitlement 保證配額）

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

request that any refund cheque(s) be made payable to me/ ‧ 要求任何退款支票以本人╱本申請表格內我們的排名首

the first-named of us (in the case of joint applicants) in this 位者（倘屬聯名申請人）為抬頭人； Application Form;

‧ have read the terms and conditions and application procedures	‧ 已細閱本申請表格隨附各頁及招股章程所載的條款和條
set out on the pages attached to this Application Form and in	件及申請程序，並同意受其約束且知悉招股章程所述有
the Prospectus and agree to be bound by them, and am aware	關優先發售的限制；
of the restrictions on the Preferential Offering described in the
Prospectus;
‧ represent, warrant and undertake that the allotment of, or	‧ 聲明、保證及承諾獲配發或申請認購預留股份不會引
application for, the Reserved Shares would not require the	致貴公司、聯席保薦人、聯席全球協調人、聯席代
Company, the Joint Sponsors, the Joint Global Coordinators,	表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從
the Joint Representatives the Joint Bookrunners, the Joint Lead	香港以外任何地區的任何法律或法規的任何規定（不論
Managers or the Underwriters to comply with any requirements	是否具法律效力）；
under any law or regulation (whether or not having the force of
law) of any territory outside Hong Kong;
‧ represent, warrant and undertake that I am not/ we are not	‧ 聲明、保證及承諾本人╱我們並非香港或其他地區任何
restricted by any applicable laws of Hong Kong or elsewhere	適用法律規定不得作出是項申請、支付任何申請款項或
from making this application, paying any application monies	獲配發或接納任何預留股份的受限制人士；及本人╱我
for, or being allotted or taking up any Reserved Shares; that I/	們明白預留股份並無亦不會根據美國證券法登記；本人
we understand that the Reserved Shares have not been and will	╱我們將在「離岸交易」（定義見美國證券法S 規例）中購
not be registered under the U.S. Securities Act; and that I/we	買預留股份；及	版
will acquire the Reserved Shares in an "offshore transaction"
(within the meaning of Regulation S under the U.S. Securities

Act); and
‧ agree that this application, any acceptance of it and the	‧ 同意本申請、任何對本申請的接納以及因此訂立的合
resulting contract, will be governed by and constru d in	約，將受香港法例規管及按其詮釋。
accordance with the laws of Hong Kong.
Warning:	警告：
‧ It is important that you read the terms and conditions and	‧ 閣下必須細閱招股章程及本申請表格所載的條款和條樣
application procedures set out in the Pros ectus and in this	件及申請程序。
Application Form.
‧ You must sign this application in writing (and not by way	‧ 閣下必須以書面方式（不得以個人印章方式）簽署本申
of personal chop), otherwise the a lication is liable to be	請，否則申請會被拒絕受理。
rejected.
‧ Only one application ay be ade for the benefit of any	‧ 任何人士僅可為本身利益以藍色申請表格就預留股份
person for Reserved Shares on a BLUE Application Form.	作出一次申請。下列情況將不獲受理：於藍色申請表
The following are liable to be rejected: ultiple or suspected	格或透過藍表eIPO 服務就預留股份作出的重複或疑屬
multiple applications for Reserved Shares on the BLUE	重複申請以及支票或銀行本票在首次過戶時未能兌現
Applic tion Form or through Blue Form eIPO service and	的申請。
applic tions where cheques or b nker's cashier orders are
dishonoured upon the first present tion.
‧ You m y be prosecuted if you m ke a false declaration.	‧ 倘閣下作出虛假聲明，則可遭檢控。
‧ All inform tion st ted in this Application Form must be	‧ 在本申請表格中聲明的所有資料必須與復星醫藥或其
the s me s th t m int ined by Fosun Pharma or any of its	任何全資附屬公司所保存者相同。
wholly-owned subsidiaries.
‧ You must complete this application in English (except	‧ 除中文姓名╱名稱外，閣下必須以英文填妥本申請
Chinese name) unless otherwise stated, otherwise the	（除非另有指明），否則申請會被拒絕受理。
application is liable to be rejected.
‧ Any alteration to any application detail that you provide on	‧ 閣下於本申請表格提供的任何申請資料如有任何更
this Application Form should be authorised by the signature	改，須由申請人簽署授權。
Sample
of the applicant.

You or, if you are joint applicants, the first-named applicant must provide your Hong Kong identity card number/ passport number/Hong Kong business registration certificate number.

‧ 閣下或（倘閣下為聯名申請人）排名首位申請人必須提供香港身份證號碼╱護照號碼╱香港商業登記號碼。

Excess	請
Application
	申
額
超

BLUE FORM 藍表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

Application Form for Excess Reserved Shares of Qualifying Fosun Pharma H Shareholders

合資格復星醫藥 H 股股東超額預留股份申請表格

For Qualifying Fosun Pharma H Shareholders,			合資格復星醫藥H 股股東的
applications will be accepted until 12:00 noon			截止接受申請時間
on Tuesday, 17 September 2019.				為二零一九年九月十七日
You must read the conditions and instructions			（星期二）中午十二時正。
attached to this Application Form.				閣下務必細閱本申請表格隨附的
To be valid, you must complete all applicable parts			條件及指示。
	of this Application Form.			本申請表格各適用部分必須以英文用墨水筆或
Please write clearly in English and in ink.			原子筆清楚填妥，方為有效。

Mixed Media Offer				混合媒介要約
The Company will be relying on Section 9A of the Companies		本公司將依據香港法例第32L 章《公司（豁免公司及招股
(Exemption of Companies and Prospectuses from Compliance		章程遵從條文）公告》第9A 條，在(i) 並非與招股章程印
with Provisions) Notice (Chapter 32L of the Laws of Hong		刷本一併發出的情況下，發出白色及黃色申請表格；及
Kong) and will be issuing the (i) WHITE and YELLOW		(ii) 並非與招股章程印刷本一併發出的情況下，向相關
Application Forms without them being accompanied by a		合資格復星國際股東發出橙色申請表格及向相關合資格
printed Prospectus; and (ii) the ORANGE Application Forms		復星醫藥H 股股東發出藍色申請表格，除非相關合資格
to the relevant Qualifying Fosun International Shareholders and		復星國際股東或相關合資格復星醫藥H 股股東（視情況
the BLUE Application Forms to the relevant Qualifying Fosun		而定）已選擇根據復星國際或復星醫藥（視情況而定）公
Pharma H Shareholders without them being accompanied by		司通訊政策收取公司通訊印刷本或未被要求選擇收取復版
a printed Prospectus, unless the relevant Qualifying Fosun		星國際或復星醫藥（視情況而定）公司通訊稿的方式，在
International Shareholders or the relevant Qualifying Fosun		此情況下，招股章程印刷本會分開寄發予彼等。招股章
Pharma H Shareholders (as the case may be) have el ct d to		程的印刷本的內容與招股章程的電子版本相同，招股章
receive corporate communications in printed form und r the		程的電子版本分別在本公司網站www.henlius.com及聯
corporate communications policy of Fosun International or		交所網站www.hkexnews.hk「披露易＞上市公司公告＞
Fosun Pharma (as the case may be), or have not been ask d to		最新上市公司公告」一欄中可供查閱及下載。
elect the means of receiving the corporate communications of		樣
Fosun International or Fosun Pharma (as the case may b ), in
which case the printed Prospectus will be des atched to them

separately. The contents of the printed Pros ectus are identical
to the electronic version of the Pros ectus which can be
accessed and downloaded from the websites of the Com any at
www.henlius.comand the Stock Exchange at www.hkexnews.
hkunder the "HKExnews > Listed Com any Information >
Latest Listed Company Infor ation " section, respectively.
Members of the public, the Qualifying Fosun International		有意索取招股章程印刷本的公眾人士、合資格復星國
Shareholders and the Qualifying Fosun Phar a H Shareholders		際股東及合資格復星醫藥H 股股東可於二零一九年九月
who wish to obt in copy of the printed Prospectus	ay obtain		十二日（星期四）上午九時正至二零一九年九月十七日
a copy, free of ch rge, upon request during nor	al business		（星期二）中午十二時正的正常辦公時間內，在以下地點
hours from 9:00	. . on Thursd y, 12 Septe ber 2019 until		免費索取：
12:00 noon on Tuesd y, 17 September 2019 at the following
locations:
1. any of the following br nches of the receiving banks of the		1. 本公司收款銀行的下列任何分行：
Comp ny:
Bank of China (Hong Kong) Limited			中國銀行（香港）有限公司
District	Branch Name	Address			地區	分行名稱	地址
Hong Kong Island	Des Voeux Road	111-119 Des Voeux Road West,		香港島	德輔道西分行	香港德輔道西
	West Branch	Hong Kong					111-119號
	Chai Wan Branch	Block B, Walton Estate,			柴灣分行	香港
Sample341-343 Chai Wan Road,				柴灣道341-343號
		Chai Wan,					宏德居B座
		Hong Kong
Kowloon	Telford Plaza Branch	Shop Unit P2-P7,		九龍	德福廣場分行	九龍灣
		Telford Plaza,					偉業街33號
		No.33 Wai Yip Street,				德福廣場
		Kowloon Bay,					P2-P7號舖
		Kowloon

Excess	請
Application
	申
額
超

BLUE FORM 藍表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

	Olympian City Branch	Shop 133, 1/F,				奧海城分行	九龍
		Olympian City 2,					海庭道18號
		18 Hoi Ting Road,					奧海城二期
		Kowloon					一樓133號
New Territories	Metro City Branch	Shop 209, Level 2,			新界	新都城分行	新界
		Metro City Phase 1,					將軍澳
		Tseung Kwan O,					新都城一期
		New Territories					二樓209號
	Ma On Shan Plaza	Shop 2103, Level 2,				馬鞍山廣場分行	新界
	Branch	Ma On Shan Plaza,					馬鞍山
		Sai Sha Road,					西沙路
		Ma On Shan,					馬鞍山廣場
		New Territories					L2層2103號
CMB Wing Lung Bank Limited				招商永隆銀行有限公司
District	Branch Name	Address			地區	分行名稱	地址
					樣	德輔道中45號
Hong Kong Island	Head Office	45 Des Voeux Road Central			香港島	總行
	Kennedy Town Branch	28 Catchick Street				堅尼地城分行	吉席街28號
Kowloon	Mongkok Branch	B/F CMB			九龍	旺角分行	彌敦道636號
		Wing Lung Bank Centre,					招商永隆
		636 Nathan Road					銀行中心地庫
	Tsim Sha Tsui Branch	4 Carnarvon Road			新界	尖沙咀分行版加拿分道4號
New Territories	Tsuen Wan Branch	251 Sha Tsui Road			荃灣分行	沙咀道251號
Sample
2. any of the following offices of	the below Joint Global		2.	以下聯席全球協調人的下列任何辦事處：
Coordinators:
China International Capital Corporation Hong Kong			中國國際金融香港證券有限公司
Securities Limited				香港
29th Floor, One International Finance Centre			中環
1 Harbour View Street				港景街1 號
Central					國際金融中心一期29 樓
Hong Kong
Merrill Lynch (Asia Pacific) Limited			Merrill Lynch (Asia Pacific) Limited
Level 55 Cheung Kong Center				香港
2 Queen's Road Central				中環
Central					皇后大道中2 號
Hong Kong					長江集團中心55 樓
BOCI Asia Li	ited				中銀國際亞洲有限公司
26th Floor, Bank of China Tower				香港
1 G rden Ro d					中環
Centr l					花園道1 號
Hong Kong					中銀大廈26 樓
UBS AG Hong Kong Br nch				UBS AG Hong Kong Branch
52/F, Two Intern tion l Fin nce Centre			香港
8 Fin nce treet					中環
Centr l					金融街8 號
Hong Kong					國際金融中心二期52 樓
CMB International Capital Limited			招銀國際融資有限公司
45/F, Champion Tower				香港
3 Garden Road					中環
Central					花園道3 號
Hong Kong					冠君大廈45 樓
Fosun Hani Securities Limited				復星恆利證券有限公司
Suite 2101-2105 21/F Champion Tower			香港
3 Garden Road					中環
Central					花園道3 號
Hong Kong					冠君大廈21 樓2101-2105室
3. the Depository Counter of HKSCC at 1/F, One & Two Exchange		3.	香港結算存管處服務櫃檯，地址為香港中環康樂廣
Square, 8 Connaught Place, Central, Hong Kong.			場8 號交易廣場一座及二座一樓。

Details of where printed Prospectuses may be obtained will be displayed prominently at every designated branch of receiving banks where WHITE Application Forms are distributed.

Excess	請
Application
	申
額
超

BLUE FORM 藍表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

可索取招股章程印刷本的地址詳情將於派發白色申請表格的收款銀行各指定分行以顯眼方式展示。

During normal business hours from 9:00 a.m. on Thursday, 12		於二零一九年九月十二日（星期四）上午九時正至二零
September 2019 until 12:00 noon on Tuesday, 17 September,		一九年九月十七日（星期二）中午十二時正的正常辦公時
2019, at least three copies of the printed Prospectus will be		間內，在派發白色及黃色申請表格的各個地點（載於招
available for inspection at every location where the WHITE		股章程「如何申請香港發售股份及預留股份」），均有至
and YELLOW Application Forms are distributed as set out in		少三份招股章程印刷本可供查閱。
the section headed "How to Apply for Hong Kong Offer Shares
and Reserved Shares" in the Prospectus.

To: Shanghai Henlius Biotech, Inc.		致：上海復宏漢霖生物技術股份有限公司
Joint Sponsors		聯席保薦人
Joint Global Coordinators		聯席全球協調人
Joint Representatives		聯席代表
Joint Bookrunners		聯席賬簿管理人
Hong Kong Underwriters		香港包銷商
I/We:		本人╱我們：
‧ being the Qualifying Fosun Pharma H Shareholder(s) named		‧ 乃名列本申請表格之合資格復星醫藥H 股股東，按照招
on this Application Form, apply for the number of excess		股章程及本申請表格所載條款及條件以及在貴公司章
Reserved Shares specified or deemed to be specified, on the				版
	程細則規限下，申請所指定或視作指定數目之超額預留
terms and conditions of the Prospectus and this Application		股份；
Form, and subject to the Articles of Association of the
Company;
‧ enclose payment in full for the excess Reserved Shar s app i d		‧ 隨附以最高發售價每股發售股份57.80 港元（多繳款項可
for at the Maximum Offer Price of HK$57.80 per Off r Share		予退還）計算申請認購超額預留股份所需的全數付款（包
(subject to refund), including a 1% brokerage fee, a 0.0027%		括1% 經紀佣金、0.0027% 證監會交易徵費及0.005% 聯
SFC transaction levy and a 0.005% Stock Exchange trading		交所交易費）；
fee;		樣

‧ undertake and agree to accept the excess Reserved Shares		‧ 承諾及同意接納本人╱我們就本申請所申請認購的超額
applied for, or any lesser number allotted to me/us on this		預留股份，或獲配發的任何較少數目；
application;
‧ warrant that this is the only application made by me/us for		‧ 保證是項申請乃本人╱我們就超額預留股份為本人╱我
excess Reserved Shares for y/our own benefit (other than an		們本身利益作出之唯一申請（除以合資格復星國際股東
application (if any) ade in the capacity as a Qualifying Fosun		身份作出的申請（如有）外）；
International Shareholder);
‧ underst nd nd confirm th t these declarations and		‧ 明白及確認貴公司及聯席代表將依賴該等聲明及陳
represent tions will be relied upon by the Co pany and the		述，以決定是否就本申請向本人╱我們配發任何超額預
Joint Represent tives in deciding whether or not to ake any		留股份，而本人╱我們如果作出虛假聲明可能會被檢
allotment of excess Reserved Sh res to me/ us in response to		椌；
this applic tion nd th t I/we m y be prosecuted for making a
false decl r tion;
‧ authorise the Comp ny to pl ce my/our name(s) on the H		‧ 授權貴公司將本人╱我們的姓名╱名稱列入H 股股東
hare register as the holder(s) of any excess Reserved Shares		名冊內，作為將配發予本人╱我們的任何超額預留股份
to be allotted to me/us and such other registers as required		的持有人，及根據	貴公司章程細則規定的其他登記冊
under the Articles of Association of the Company, and		內，並按本申請表格上所示地址以普通郵遞方式向本人
despatch any hare certificate(s) (where applicable) and/or any		╱我們寄發任何股票（如適用）及╱或任何退款支票（如
refund cheque(s) (where applicable) to me/us by ordinary post		適用），郵誤風險概由本人╱我們自行承擔（除非本人╱
at my/ our own risk to the address stated in this Application		我們申請1,000,000 股或以上超額預留股份，且本人╱
Sample
Form unless I/we have applied for 1,000,000 excess Reserved		我們符合資格按本申請表格所述親自領取任何股票及╱
Shares or more and I/we am/are eligible to collect any Share		或任何退款支票（如適用））；

certificate(s) and/or any refund cheque (where applicable) personally, as provided in this Application Form;

undertake to sign all documents and to do all things necessary to enable me/us to be registered as the holder of the excess Reserved Shares to be allocated to me/ us, and as required by the Articles of Association of the Company;

‧ 承諾簽署所有文件並採取所有必要的事宜，以及根據貴公司章程細則規定讓本人╱我們登記為本人╱我們獲分配超額預留股份的持有人；

Excess	請
Application
	申
額
超

BLUE FORM 藍表 (Excess Application 超額申請)

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and

have difficulties applying online via www.eipo.com.hk

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

request that any refund cheque(s) be made payable to me/ ‧ 要求任何退款支票以本人╱本申請表格內我們的排名首

the first-named of us (in the case of joint applicants) in this 位者（倘屬聯名申請人）為抬頭人； Application Form;

‧ have read the terms and conditions and application procedures	‧ 已細閱本申請表格隨附各頁及招股章程所載的條款和條
set out on the pages attached to this Application Form and in	件及申請程序，並同意受其約束且知悉招股章程所述有
the Prospectus and agree to be bound by them, and am aware	關優先發售的限制；
of the restrictions on the Preferential Offering described in the
Prospectus;
‧ represent, warrant and undertake that the allotment of,	‧ 聲明、保證及承諾獲配發或申請認購超額預留股份不會
or application for, the excess Reserved Shares would not	引致貴公司、聯席保薦人、聯席全球協調人、聯席代
require the Company, the Joint Sponsors, the Joint Global	表、聯席賬簿管理人、聯席牽頭經辦人或包銷商須遵從
Coordinators, the Joint Representatives, the Joint Bookrunners,	香港以外任何地區的任何法律或法規的任何規定（不論
the Joint Lead Managers or the Underwriters to comply with	是否具法律效力）；
any requirements under any law or regulation (whether or not
having the force of law) of any territory outside Hong Kong;
‧ represent, warrant and undertake that I am not/we are not	‧ 聲明、保證及承諾本人╱我們並非香港或其他地區任何
restricted by any applicable laws of Hong Kong or elsewhere	適用法律規定不得作出是項申請、支付任何申請款項或
from making this application, paying any application monies	獲配發或接納任何超額預留股份的受限制人士；及本人
for, or being allotted or taking up any excess Reserved Shares;	╱我們明白超額預留股份並無亦不會根據美國證券法登
that I/we understand that the excess Reserved Shares have not	記；本人╱我們將在「離岸交易」（定義見美國證券法S
been and will not be registered under the U.S. Securities Act;	規例）中購買超額預留股份；及
and that I/we will acquire the excess Reserved Shares in an		版

"offshore transaction" (within the meaning of Regulation S
under the U.S. Securities Act); and
‧ agree that this application, any acceptance of it and the	‧ 同意本申請、任何對本申請的接納以及因此訂立的合
resulting contract, will be governed by and constru d in	約，將受香港法例規管及按其詮釋。
accordance with the laws of Hong Kong.	警告：樣
Warning:
‧ It is important that you read the terms and conditions and	‧ 閣下必須細閱招股章程及本申請表格所載的條款和條
application procedures set out in the Pros ectus and in this	件及申請程序。
Application Form.
‧ You must sign this application in writing (and not by way	‧ 閣下必須以書面方式（不得以個人印章方式）簽署本申
of personal chop), otherwise the a lication is liable to be	請，否則申請會被拒絕受理。
rejected.
‧ Only one application ay be ade for the benefit of any	‧ 任何人士僅可為本身利益以藍色申請表格就超額預留
person for excess Reserved Shares on a BLUE Application	股份作出一次申請。下列情況將不獲受理：於藍色申
Form. The following re li ble to be rejected: ultiple or	請表格或透過藍表eIPO 服務就超額預留股份作出的重
suspected multiple pplic tions for excess Reserved Shares	複或疑屬重複申請以及支票或銀行本票在首次過戶時
on the BLUE Applic tion Form or through Blue Form	未能兌現的申請。
eIPO service nd pplic tions where cheques or banker's
cashier orders re dishonoured upon the first presentation.
‧ You m y be prosecuted if you m ke a false declaration.	‧ 倘閣下作出虛假聲明，則可遭檢控。
‧ All information stated in this Application Form must be	‧ 在本申請表格中聲明的所有資料必須與復星醫藥或其
the same as that maintained by Fosun Pharma or any of its	任何全資附屬公司所保存者相同。
wholly-owned subsidiaries.
‧ You must complete this application in English (except	‧ 除中文姓名╱名稱外，閣下必須以英文填妥本申請
Chinese name) unless otherwise stated, otherwise the	（除非另有指明），否則申請會被拒絕受理。
application is liable to be rejected.
‧SampleAny alteration to any application detail that you provide on ‧ 閣下於本申請表格提供的任何申請資料如有任何更
this Application Form should be authorised by the signature	改，須由申請人簽署授權。
of the applicant.
‧ You or, if you are joint applicants, the first-named applicant	‧ 閣下或（倘閣下為聯名申請人）排名首位申請人必
must provide your Hong Kong identity card number/	須提供香港身份證號碼╱護照號碼╱香港商業登記號
passport number/Hong Kong business registration certificate	碼。

number.

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

Shanghai Henlius Biotech, Inc.

上海復宏漢霖生物技術股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

			GLOBAL OFFERING	版
Conditions of your Application
					Notwithstanding any other provision in the Prospectus
Unless otherwise stated, terms used in these conditions have	or this Application Form or the terms and conditions of
the same meanings ascribed thereto in the Prospectus.			the Blue Form eIPO service, the Company reserves
A. Who can apply							the right to permit any Fosun Pharma H Shareholder to
1. You, the applicant(s), and any person(s) for whose	take up his/her/its Assured Entitlement to the Reserved
benefit you are applying, must be Qualifying Fosun	Shares if the Company, in its absolute discretion, is
Pharma H Shareholder(s) and must be 18 years of age	satisfied that the transaction in question is exempt from
							樣
or above.							or not subject to the legislation or regulations giving rise
2. If you are a firm, the application must be in the names	to the restrictions described above.
of the individual members, not in the name of the	5. The number of joint applicants may not exceed four.
firm.							B. Allocation of Reserved Shares
3. If you are a body corporate, the application must	A valid application for a number of Reserved Shares that
Sample
be stamped with the company chop (bearing the	is less than or equal to your Assured Entitlement will be
company name) and signed by a duly authoris d	acc pt d in full, subject to the terms and conditions set out
officer, who must state his or her repres ntative	in this Application Form and assuming that the conditions
capacity.							of the Pr f r ntial Offering are satisfied. If an application
4. Save under the circumstances permitted by the	is made for a number of Reserved Shares that is less than
Listing Rules and guidance letters issued by the Stock	your Assur d Entitlement, you MUST apply for a number
Exchange, or any	relevant waivers that	have b	n	in one of the numbers set out in the table of numbers and
granted by the Stock Exchange, you cannot a	y for	payments in this Application Form and make a payment of
any Reserved Shares if you or (with the exce	tion of	the corresponding amount (other than HKSCC Nominees).
HKSCC Nominees) any person(s) for whose benefit	If you intend to apply for a number of Assured Entitlement
you are applying are/is:						which is not one of the numbers set out in the table in
‧ an existing beneficial owner	of Shares	in	the	the BLUE Application Form for Assured Entitlement,
Company and/or any of its subsidiaries;				you MUST apply by using Blue Form eIPO only. If
‧ a director or chief executive of the Co	pany and/	you wish to apply for excess Reserved Shares in addition
or any of the Co	pany's subsidiaries;				to your Assured Entitlement, you should complete and
‧ n ssoci te of	ny of the bove persons;			sign the BLUE Application Form for excess Reserved
		Shares and lodge it, together with a separate remittance
‧ connected person of the Co	pany or a person
for the full amount payable on application in respect of the
who will beco	e	connected person	of	the
excess Reserved Shares applied for or apply for through
Comp ny immedi tely upon completion of the
the Blue Form eIPO service via www.eipo.com.hk. If
Glob l Offering; or
					an application is made for a number of Reserved Shares
‧ Non-Qu lifying Fosun Pharma H Shareholder.
that is greater than your Assured Entitlement, the relevant
Non-Qualifying Fosun Pharma H Shareholders are	application for Assured Entitlement will be satisfied in
those Fosun Pharma H Shareholders with registered	full, but the application for excess Reserved Shares will
addresses in, or who are otherwise known by Fosun	only be met to the extent that there are sufficient Available
Pharma to be residents of, jurisdictions outside Hong	Reserved Shares. To the extent that excess applications for
Kong on the Record Date, in respect of whom the	the Reserved Shares are:
directors of Fosun Pharma and the Company, based	(i) less than the Available Reserved Shares, the Available
on the enquiries made by them, consider it necessary	Reserved Shares will first be allocated to satisfy such
or expedient to exclude from the Preferential Offering	excess applications for the Reserved Shares in full
on account either of the legal restrictions under the	and thereafter will be allocated, at the discretion of the
laws of the relevant jurisdiction in which the relevant	Joint Representatives, to the International Offering;
Fosun Pharma H Shareholder is resident or the	(ii)equal to the Available Reserved Shares, the Available
requirements of the relevant regulatory body or stock	Reserved Shares will be allocated to satisfy such
exchange in that jurisdiction.					excess applications for the Reserved Shares in full; or

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

(iii) more	than the Available Reserved Shares, the	applications will not be valid. Subject to the above, an
Available Reserved Shares will be allocated on an	application once made is irrevocable and applicants shall
allocation basis which will be consistent with the	be deemed to have applied on the basis of the Prospectus
allocation basis commonly used in the case of over-	as supplemented.
subscriptions in public offerings in Hong Kong, where	D. Effect of completing and submitting this Application
a higher allocation percentage will be	applied in
Form
respect of smaller applications. If there are any Shares
By completing and submitting this Application Form, you
left after satisfying	the excess applications, such
(and if you are joint applicants, each of you jointly and
Shares	will be re-allocated, at	the discretion of the
severally) for yourself or as an agent or a nominee and on
Joint Representatives, to the International Offering.
behalf of each person for whom you act as an agent or a
No preference will be given to any excess applications
nominee:
made to top up odd lot holdings to whole lot holdings
‧ instruct and authorise	the Company and/or Joint
of Shares.
				Representatives	(or their respective agents	or
Save for	the above, the	Preferential Offering	will not
nominees), to execute any transfer forms, contract

be subject to the clawback arrangement between the	樣
International Offering	and the	Hong Kong	Public	notes or other documents on your behalf and to do
Offering. Any application not accompanied by the correct	on	your behalf	all other things necessary to effect
amount of application monies will be treated as invalid	the registration of any Reserved Shares allocated to
in its entirety and no Reserved Shares will be allotted to	you in your name(s) as required by the Articles of
						Association of the Company and otherwise to give
such applicant.					effect to the arrangements版described in the Prospectus
Sample
In addition to any application for Reserved Shares made	and this Application Form;
through the Blue Form eIPO services via	www. ipo.	‧ und rtake to	sign	all	documents and to do	all
com.hkor on the BLUE Application Form, Qualifying	things n cessary	to	enable you to be	registered	as
Fosun Pharma H Shareholders will be entit ed to make	the hold r of the Reserved Shares allocated to you,
one application for Hong Kong Offer Shares on WHITE	and as r quired by the Articles of Association of the
or YELLOW Application Forms or by giving e	ctronic	Company;
application instructions to HKSCC via CCASS or by	‧ r pr s nt, warrant	and undertake that you
applying through the White Form eIPO service.		understand that the Reserved Shares have not been
Qualifying Fosun Pharma H Shareholders wi	receive	and will not be registered under the U.S. Securities
no preference as to entitlement or allocation in res ect	Act; and that,	with the exception	of HKSCC
of applications for Hong Kong Offer Shares made on	Nominees, you	or	any other person for whose
WHITE or YELLOW Application Form or by giving	account or benefit you are acquiring Reserved Shares
electronic application instructions to HKSCC or through	are	outside the	United	States	(within	the meaning
the White Form eIPO service under the Hong Kong	of	Regulation	S), and	are a	person	described	in
Public Offering.					paragraph (h)(3) of Rule 902 of Regulation S;
Qualifying Fosun Ph r	H Shareholders	are	entitled
‧ confirm that you have only relied on the information
to apply on the b sis of	n Assured Entitle	ent of one
and representations	contained	in the	Prospectus	in
Reserved Sh re for every integr l	ultiple of 132 Fosun
making this application, and will not rely on any other
Pharma H	h res held by e ch Qualifying Fosun Pharma
information or representation save as set out in any
H h reholder on the Record Date. Qualifying Fosun
supplement to the Prospectus;
Pharma H h reholders who hold less than 132 Fosun
‧ agree that none of the Company,	the Relevant
Pharma H hares on the Record Date will not have an
Persons or the Orange and Blue Form eIPO Service
Assured Entitlement to the Reserved Shares, but they will
Provider is or	will	be	liable	for any information
still be entitled to participate in the Preferential Offering
and representations	not	in the	Prospectus (and any
by applying for excess Reserved Shares.
		supplement to it);

C. Supplemental information				‧ agree (without prejudice to any other rights which
If any supplement to the Prospectus is issued, applicant(s)	you may have) that once this application has been
who have already submitted an application may or may	accepted, you may not rescind it due to an innocent
not (depending on the information contained in the	misrepresentation;
supplement) be notified that they are required to confirm	‧ (if the application is made by an agent on your
their applications. If applicant(s) have been so notified	behalf) warrant that you have validly and irrevocably
but have not confirmed their applications in accordance	conferred on your agent all necessary power and
with the	procedure to	be notified, all unconfirmed	authority to make this application;

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

‧ (if you are an agent for another person) warrant that

‧ agree that the processing of your application,

reasonable enquiries have been made of the beneficial

including the despatch of refund cheque(s) (if any),

owner that this application is the only application

may be done by any of the receiving banks and is not

which will be made for the benefit of that other

restricted to the bank at which your Application Form

person on a BLUE Application Form and that you are

is lodged;

duly authorised to sign this Application Form as that

‧ confirm that you are aware of the restrictions on the

other person's agent;

Preferential Offering of the Reserved Shares described

‧ agree that

once

your application

accepted, your

in the Prospectus;

版

application

will

be evidenced

the

results

of the

‧ understand that these declarations and representations

Preferential Offering made available by the Company;

will be relied upon by the Company and the Joint

‧ warrant the truth and accuracy of the information

Representatives in deciding whether or not to allocate

contained in this application;

any Reserved Shares in response to your application;

‧ agree to disclose to the

Company, the H

Registrar, the receiving banks, the Relevant Persons

‧ if the laws of any place outside Hong Kong are

applicable to your application, you agree and warrant

and the Orange and Blue Form eIPO Service

樣

Provider any personal data about you or, with the

that you have complied with all such laws and

exception of HKSCC Nominees, the person(s) for

none of the Company nor the Relevant Persons will

whose benefit you have made the application which

infringe any laws outside Hong Kong as a result of

they require;

the acceptance of your offer to purchase any Reserved

‧ warrant that, in making an application, you or any

Shares, or any actions arising from your rights and

person(s) on whose behalf you may be acting is/are

obligations under the terms and conditions contained

Sample

Qualifying Fosun Pharma H Shareholder(s);

in the Prospectus;

‧ represent, warrant and undertake that in making

‧ agr

with the Company and for the benefit of each

this application,

you and/or, with

the exception of

Shar holder (and

that

the Company

shall be

HKSCC Nominees, any person(s) for whose b ha f

d m d by their acceptance in whole or in part of this

you may be acting are not connected person(s) or

application to have agreed, for itself and on behalf of

person(s) who will become connected person(s) of the

ach Shar holder) (and if applicable, with each CCASS

Company immediately upon completion of the G obal

Participant giving

electronic

application instructions),

Offering, the subscription for Reserved Shares by you

and the Company agree with each Shareholder, to

and/or, with the exception of HKSCC Nominees, any

observe and comply with the Companies Ordinance

person(s) on whose behalf you may be acting is not

(Chapter 622 of the Laws of Hong Kong), the

financed directly or indirectly by a connected

erson

Companies (Winding Up and Miscellaneous Provisions)

of the Company, and you and/or, with the exce tion

of HKSCC No inees, any person(s) on whose behalf

Ordinance (Chapter 32 of the Laws of Hong Kong) and

you may be acting is not taking instructions from

the Articles of Association of the Company;

a connected person of the Co

pany in

aking this

‧ agree with the Company and each Shareholder that

subscription for Reserved Sh res;

the Shares are freely transferable by the Shareholder;

‧ agree th t your

pplic tion, any acceptance of it

and

and the resulting contr ct will be governed by and

‧ understand that

the

Company

and

the

Relevant

construed in ccord nce with the laws of Hong Kong;

Persons are

entitled

to rely

any

warranty,

‧ undert ke

gree to

ccept the Reserved Shares

representation

declaration made

you in this

applied for,

ny lesser

number

allocated

to you

application. In the event of the application being made

under the application;

by joint applicants, all the warranties, representations,

‧ authorise the Company to place your name(s) on

declarations and obligations

expressed

made,

the Company's H hare register of members as the

given

or assumed by or

imposed

the

joint

holder(s) of any Reserved Shares allocated to you and

applicants shall be deemed to have been made, given

such other registers as required under the Company's

and assumed by and imposed on the applicants jointly

Articles of

Association,

and

despatch

any

and severally. You may be prosecuted if you make a

certificate(s) (where applicable) and/or any refund

false declaration.

cheque(s) (where applicable) to you or (in case of

joint applicants) the first-named applicant in this

You must complete this application in English,

Application Form by ordinary post at your own risk

unless otherwise stated, and you or (in case of joint

to the address stated on this Application Form (except

applicants) each of the joint applicants must sign this

if you have applied for 1,000,000 Reserved Shares or

application in writing (and not by way of personal

more you may collect your refund cheque and Share

chop), otherwise the application is liable to be

certificates (where applicable) in person);

rejected.

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

E. Power of attorney				If you do not collect your refund cheque(s) and/or share
If your application is made by a person, duly authorised	certificate(s) personally within the time period specified for
under a valid power of attorney, the Company and the	collection, they will be despatched promptly to the address
			'		as specified on this Application Form by ordinary post at
Joint Representatives, as the Company s agent, may
accept it at their discretion and on any conditions they	your own risk.
think fit, including requiring evidence of the attorney's	If you apply for less than 1,000,000 Reserved Shares, your
authority. The Company and the Joint Representatives, as	refund cheque(s) and/or share certificate(s) will be sent to
the Company's agents, will have full discretion to reject	the address in your Application Form on or before Tuesday,
or accept any application, in full or in part without giving	24 September 2019, by ordinary post and at your own risk.
any reason.					版
			The Company will not issue temporary documents of title.
F. Determination of Offer Price			Share certificates will only become valid at 8:00 a.m. on
The Offer Price is expected to be fixed on or around	Wednesday, 25 September 2019 provided that the Global
Tuesday, 17 September 2019. Applicants are required	Offering has become unconditional in all respects and the
to pay the Maximum Offer Price of HK$57.80 for	right of termination under the Underwriting Agreements
each Offer Share (subject to refund) together with	and described in the section headed "Underwriting" in
1% brokerage fee, 0.0027%	SFC transaction	levy	the Prospectus has not been exercised. No receipt will be
					樣
and 0.005% Stock Exchange trading fee. If the Offer	issued for sums paid on application. In the event that the
Price is not agreed among the Company and the Joint	Offer Price is less than the price per Reserved Share paid
Representatives (on behalf of the Underwriters) on or	by you, the surplus application money (including the
before Tuesday, 24 September 2019, the Global Offering	brokerage fee, the SFC transaction levy and the Stock
will not proceed and will lapse.			Exchange trading fee attributable to such surplus) will
Allotment of Reserved Shares			be refunded to you without interest. Investors who trade
Subject to the terms and conditions as set out herein and in	Shares prior to the receipt of Share certificates or prior
to the Share c rtificates becoming valid do so entirely at
the Prospectus, the Reserved Shares will be allotted aft r the
th ir own risk.
application lists close.

The Company expects to announce the Offer Price, the	v	Circumstanc s in which you will not be allotted Reserved
of indications of interest in the International Offering, the	Shar s
level of applications under the Hong Kong Pub ic Off ring	You may not be allocated Reserved Shares for any of the
and the Preferential Offering, and the basis of a ocation of	fo owing r asons:
the Hong Kong Offer Shares and the Reserved Shares on
1. If your application is revoked:
Tuesday, 24 September 2019 in South China Morning Post	By completing and submitting an Application Form or
(in English), Hong Kong Economic Times (in Chinese),	giving electronic application instructions	to HKSCC or
the website of the Stock Exchange at www.hkexnews.hk
through the Blue Form eIPO service,	you agree that
and the Company's website www.henlius.com. Results of
your application or the application made by HKSCC
allocations and the Hong Kong Identity Card/ ass ort/Hong
Nominees on your behalf cannot be revoked on or before
Kong business registration nu	bers of successful applicants
the expiration of the fifth day after the time of the opening
under the Hong Kong Public Offering and the Preferential
of the application lists (excluding for this purpose any day
Offering will be available on the above websites.
	which is not a business day), unless a person responsible

If your	pplic tion for Reserved Shares is successful (in	for the Prospectus under Section 40 of the Companies
whole or in p rt)				(Winding Up and Miscellaneous Provisions) Ordinance
If you apply for 1,000,000 or	ore Reserved Shares and have	(Chapter 32 of the Laws of Hong Kong) gives a public
provided	ll inform tion required by this Application Form, you	notice under that section which excludes or limits the
may collect your refund cheque(s)	nd/or share certificate(s)	responsibility of that person for the Prospectus. This
from Computersh re Hong Kong Investor Services Limited, at	agreement will take effect as a collateral contract with
hops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's	the Company, and will become binding when you lodge
Road East, Wanchai, Hong Kong, from 9:00 a.m. to 1:00 p.m.	this Application Form. This collateral contract will be
on Tuesday, 24 eptember 2019 or such other place or date as	in consideration of the Company agreeing that they will
notified by us in the newspapers.				not offer any Reserved Shares to any person on or before
If you are an individual who is eligible for personal collection,	Tuesday, 24 September 2019, except by means of one of

Samplethe procedures referred to in the Prospectus.
you must not authorise any other person to collect for you. If	If your application has been accepted, it cannot be
you are a corporate applicant which is eligible for personal	revoked. For this purpose, acceptance of applications
collection, your authorised representative must provide a letter
of authorisation from your corporation stamped with your	which are not rejected will be constituted by notification
corporation's chop.				in the announcement of the results of allocation, and
Both individuals and authorised representatives must	where such basis of allocation is subject to certain
produce, at the time of collection, evidence of identity	conditions or provides for allocation by ballot, such
acceptable to Computershare Hong Kong Investor Services	acceptance will be subject to the satisfaction of such
Limited.					conditions or results of the ballot, respectively.

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

2. Full discretion of the Company, the Joint	‧ the Company believe that by accepting the application,
Representatives, and their respective agents or	the Company would violate the applicable securities or
nominees, to reject or accept your application:	other laws, rules or regulations of the jurisdiction where
The Company and the Joint Representatives or its or	this Application Form is received or where the applicant is
their respective agents or nominees, have full discretion	resident; or
to reject or accept any application, or to accept only part	‧ the Company and the Joint Representatives, and
of any application. No reasons have to be given for any	their respective agents or nominees, exercise their
rejection or acceptance.				discretion to reject or accept any application, or to
							版
3. If the allotment of Reserved Shares is void:		accept only part of any application. No reasons have
The allotment of Reserved Shares to you will be void if	to be given for any rejection or acceptance.
the Listing Committee does not grant permission to list	5. If you are applying by using the BLUE Application Form
the Shares either:					for Assured Entitlement, you may apply for a number of
‧ within three weeks from the closing of the application	Reserved Shares pursuant to your Assured Entitlement that
lists; or					is equal to or less than the number stated in Box B. If you
‧ within a longer period of up to six weeks if the Listing	intend to apply for a number of Reserved Shares that is
Committee of the Stock Exchange notifies the Company
less than your Assured Entitlement, you MUST apply for a
of that longer period within three weeks of the closing
number which is one of the numbers set out in the table in
date of the application lists.
		the BLUE Application Form and make a payment of the
4. You will not receive any allotment if:
		corresponding amount (other than HKSCC Nominees).
‧ this Application Form is not completed in accordance
with the instructions as stated herein;		You need to complete and sign the BLUE Application
‧ this Application Form has not been duly signed (only	Form for Assured Entitlement and submit one cheque (or
Sampledishonoured on its first presentation;
written signatures are acceptable) (or in the case of a	banker's cashier order) for the exact amount of remittance
joint application, not all applicants have signed);	print d in Box B or the corresponding amount payable
‧ in respect of applicants who are corporate entiti s, this	as s t out in the table in the BLUE Application Form. If
Application Form has not been duly signed (on y writt n	you int nd to apply for a number of Assured Entitlement
signature is acceptable) by an authorised offic r or	which is not one of the numbers set out in the table in
affixed with a company chop;			the BLUE Application Form for Assured Entitlement,
‧ the	cheque/banker's cashier order/this App ication	you MUST apply by using Blue Form eIPO only. If you
Form is defective;				樣
‧ this Application Form is not accom anied with a	wish to apply for excess Reserved Shares in addition to
your Assured Entitlement, you should complete and sign
cheque/banker's cashier order or is accom anied by	the BLUE Application Form for excess Reserved Shares
more than one cheque/banker's cashier order for each	and lodge it, together with a separate remittance for
of the application for Assured Entitlement and excess	the full amount payable on application in respect of the
application for Reserved Shares;			excess Reserved Shares applied for or apply for through
‧ the account na	e on cheque/banker's cashier order is	the Blue Form eIPO service via www.eipo.com.hk.
not pre-printed or certified by the issuing bank;
‧ the cheque/banker's cashier order is not drawn on a	6. If you are applying by using the BLUE Application
Hong Kong doll r b nk	ccount in Hong Kong;	Form for excess Reserved Shares, you MUST apply for
‧ the n me of	the p yee indicated on the cheque/	a number which is one of the numbers set out in the table
b nker's c shier order is not "BANK OF CHINA	in the BLUE Application Form for excess Reserved
(HONG KONG) NOMINEES LIMITED -	Shares and make a payment of the corresponding
HENLIUS BIOTECH PREFERENTIAL	amount (other than HKSCC Nominees). You need to
OFFER";					complete and sign the BLUE Application Form for
‧ the cheque h s not been crossed "Account payee	excess Reserved Shares and submit a separate cheque
only";					(or banker's cashier order) for the exact amount of
‧ the cheque was post-dated;			remittance. If you intend to apply for a number of excess
‧ the	applicant's payment is not made correctly or
Reserved Shares which is not one of the numbers set out
the	applicant	pays by	cheque or	banker's	cashier
in the table in the BLUE Application Form for excess
order and the	cheque	or banker's	cashier	order is
Reserved Shares, you MUST apply by using Blue Form

‧ the applicant's name/the first applicant's name on	eIPO only.

the joint application is not the same as the name pre- 7. If you intend to apply for both Reserved Shares pursuant
printed or certified/endorsed by a person authorised	to your Assured Entitlement and excess Reserved Shares,
				'		you must submit both the BLUE Application Form for
by the drawee bank on the cheque/banker s cashier
order;					Assured Entitlement and the BLUE Application Form for
‧ alteration(s) to the application details on this	excess Reserved Shares. Each BLUE Application Form
Application Form has not been authorised by the	must be accompanied by a separate cheque (or banker's
signature(s) of the applicant(s);			cashier order) for the exact amount of remittance.

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

Refund of your money

or otherwise render their services. It may also prevent

If you do not receive any Reserved Shares or if your

or delay registration or transfer of the Reserved Shares

application is accepted only in part, the Company will

which you have successfully applied for and/or the

refund to you your application monies (including the

despatch of Share certificate(s), and/or the despatch of

related 1% brokerage fee, 0.0027% SFC transaction levy

refund cheque(s) to which you are entitled.

and 0.005% Stock Exchange trading fee) or the appropriate

It is important that holders of securities inform the

portion thereof without interest. If the Offer Price is less

Company and the H Share Registrar immediately of any

than the Maximum Offer Price, the Company will refund to

inaccuracies in the personal data supplied.

you the surplus application monies (including the related 1%

Purposes

brokerage fee, 0.0027% SFC transaction levy and 0.005%

The personal data of the applicants and the holders of

Stock

Exchange

trading fee)

without

interest. The

refund

securities may be used, held and/or stored (by whatever

procedures

are

stated in

the

"H. Despatch/Collection of

means) for the following purposes:

Certificates/e-Refund

Payment

Institutions/Refund

‧ processing

your application and

refund cheque,

Cheques" in the "How to Apply for Hong Kong Offer

where applicable, and verification of compliance with

Shares and Reserved Shares" section of the Prospectus.

the terms and application procedures set out in this

Effect of the Information You Give to Computershare

Application Form and the Prospectus and announcing

Hong Kong Investor Services Limited

results of allocations of the Reserved Shares;

Computershare Hong Kong Investor Services Limited and

‧ enabling compliance with all applicable laws and

its related bodies' corporate, directors, officers, employees

regulations in Hong Kong and elsewhere;

and agents

("Representatives")

expressly disclaim and

‧ registering

new issues

or transfers

into or out

the name of

holders

of securities including, where

exclude to the maximum extent permitted by law any

版

liability for any loss or damage suffered or incurred by the

applicable, in the name of HKSCC Nominees;

‧ maintaining

or updating

the registers of holders

applicant or any other person or entity however caus d

s curiti s of the Company;

relating in any way to, or connected with, any information

‧ conducting

or assisting

in the conduct

of signature

provided by or on behalf of the applicant on or in conn ction

v rifications,

any other

verification

exchange

with this document or any services provided hereund r, or

information;

any other written or oral communication provided by or on

‧ stablishing

benefit

entitlements

holders

behalf

of the applicant in

connection

with this docum nt

樣

or any services provided hereunder. This inc udes, without

s curiti s of the Company, such as dividends, rights

issues and bonus issues, etc.;

limitation, any errors or omissions in such information

‧ distributing communications from the Company and

however caused, or the Representatives or any other

erson

its subsidiaries;

or entity placing any reliance on such information or any

‧ compiling statistical information and profiles of

documentation, image, recording or re roduction of such

holders of securities;

information, or its accuracy, co

leteness, currency or

‧ making disclosures as required by laws, rules or

reliability.

regulations (whether statutory or otherwise) in Hong

Personal Data

Kong or elsewhere;

‧ disclosing relevant information to facilitate claims on

Personal inform tion collection st

ent

entitlements; and

The main

provisions of

the Personal Data (Privacy)

‧ any other incidental or

associated purposes relating

Ordinance (Ch pter 486 of the L ws of Hong Kong) (the

to the above and/or to enable the Company and the

"Ordinance") c me into effect in Hong Kong on December

H Share Registrar to

discharge their obligations

20, 1996. This Person l Inform tion Collection Statement

holders of

securities

and/or regulators

and/or other

informs the

pplic nt for

nd holder of the Hong Kong

purpose to which the holders of securities may from

Offer

hares of the policies and practices of the Company

time to time agree.

and its H hare Registrar in relation to personal data and the

Transfer of personal data

Ordinance.

Personal data held by the Company and the H Share

1. Reasons for the collection of your personal data

Registrar relating to the

applicants and

the holders

From time to time it

necessary for applicants for

securities will be kept confidential but the Company

Sample

securities or registered holders of securities to supply

and the H Share Registrar, to the extent necessary for

their latest correct personal data to the Company and

achieving the above purposes or any of them, may make

its H Share Registrar when applying for securities or

such enquiries as they consider necessary to confirm the

transferring securities into or out of their names or in

accuracy of the personal data and in particular, they may

procuring the services of the H Share Registrar. Failure to

disclose, obtain or transfer (whether within or outside

supply the requested data may result in your application

Hong Kong) the personal data of the applicants and the

for securities being rejected or in delay or inability of

holders of securities to, from or with any and all of the

the Company or its H Share Registrar to effect transfers

following persons and entities:

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

‧ the	Company or their respective appointed agents	in Box B in the Application Form. If you intend to apply
	such as financial advisors and receiving bankers;	for a number of Reserved Shares that is less than your
‧ HKSCC and HKSCC Nominees, who will use the	Assured Entitlement, you MUST apply for a number
	personal data for the purposes of operating CCASS	which is one of the numbers set out in the table in the
	(in cases where the applicants have requested for the	BLUE Application Form for Assured Entitlement, you
	Reserved Shares to be deposited into CCASS);	should (i) write the number of Reserved Shares applied
‧ any agents, contractors or third-party service providers who	for and the amount payable (as set out in the table in the
	offer administrative, telecommunications, computer,	Application Form); (ii) complete and sign the Application
	payment or other services to the Company and/or the	Form; and (iii) submit one cheque (or banker's cashier
	H Share Registrar in connection with the operation of	order) for the same amount that you have written in the
	their respective businesses;				Application Form (other than HKSCC Nominees). If
‧ the Stock Exchange, the SFC and any other statutory,	you intend to apply for a number of Assured Entitlement
	regulatory or governmental bodies in Hong Kong or	which is not one of the numbers set out in the table in the
	elsewhere; and					BLUE Application Form for Assured Entitlement, you
‧ any other	persons or institutions with which the	MUST apply by using Blue Form eIPO only. If you wish
	holders of securities have or propose to have dealings,	to apply for excess Reserved Shares in addition to your
	such as their bankers, solicitors, accountants or	Assured Entitlement, you should complete and sign the
	stockbrokers.					BLUE Application Form for excess Reserved Shares and
4. Retention of personal data				lodge it, together with a separate remittance for the full
			amount payable on application in respect of the excess
The Company and its H Share Registrar will keep the
Reserved Shares applied for版or apply for through the Blue
personal data of the applicants and holders of securities
Sample
for as long as necessary to fulfil the purposes for which	Form eIPO service via www.eipo.com.hk. If you intend
the	personal data	were collected. Personal data which	to apply for a number of Reserved Shares that is equal to
is no longer required will be destroyed or dea t with in	your Assur d Entitlement, you should (i) complete and
accordance with the Ordinance.				sign the Application Form and (ii) submit one cheque (or
5. Access to and correction of personal data		bank r's cashier order) for the exact amount of remittance
	print d in Box B in the Application Form.
The Ordinance provides the applicants and the ho d rs of	If you樣are applying by using the BLUE Application
securities with rights to ascertain whether the Com any	Form for excess Reserved Shares, you should (i) write
or	the	H Share Registrar holds their	ersonal data, to	the number of excess Reserved Shares applied for and the
obtain a copy of that data, and to correct any data that	amount payable (as set out in the table on the Application
is inaccurate. In accordance with the Ordinance, the	Form); (ii) complete and sign the Application Form; and
Company and the H Share Registrar have the right	(iii) submit one separate cheque (or banker's cashier
to charge a reasonable fee for the processing of any	order) for the same amount that you have written on the
data access request. All requests for access to data or	Application Form. The number of excess Reserved Shares
correction of data or for infor	ation regarding policies	that you intend to apply for MUST be one of the numbers
and pr ctices	nd kinds of d ta held should be addressed	set out in the table in the Application Form for excess
to	the	Comp ny,	t its registered address disclosed	Reserved Shares (other than HKSCC Nominees). If you
in	the	section	he ded "Corpor te Infor	ation" in the	intend to apply for a number of excess Reserved Shares
Prospectus or	s notified from time to time in accordance	which is not one of the numbers set out in the table in the
with	pplic ble l w, for the	ttention	of	the company	BLUE Application Form for excess Reserved Shares, you
secret ry, or the H	h re Registr r for the attention of the	MUST apply by using Blue Form eIPO only.
privacy compliance officer.				2. Complete the form and sign it. Only written signatures
By signing this Application Form, you agree to all of the	will be accepted.
3. Staple your cheque or bank's cashier order to the form.
above.
						You must pay for the application for Assured Entitlement
How to make your application
			by one cheque or by one banker's cashier order and/
Instead of using the BLUE Application Form, you may	or pay for the application for excess Reserved Shares
apply for Reserved Shares through the Blue Form eIPO
by one cheque or by one banker's cashier order. Each
service at www.eipo.com.hkand make payment using	application must be accompanied by either a separate
PPS or the internet banking payment methods.	cheque or banker's cashier order.
1. If you are applying by using the BLUE Application	If you pay by cheque, the cheque must:
Form for Assured Entitlement, you may apply for a	‧ be in Hong Kong dollars;
number of Reserved Shares pursuant to your Assured	‧ be drawn on your Hong Kong dollar bank account in
Entitlement that is equal to or less than the number stated	Hong Kong;

BLUE FORM

Please use this Application Form if you are a Qualifying Fosun Pharma H Shareholder and have difficulties applying online via www.eipo.com.hk

‧ show your account name. This name must either be	CMB Wing Lung Bank Limited
preprinted on the cheque, or be endorsed at the back	District	Branch Name	Address
by a person authorised by the bank. This account

name must be the same name as the name on this	Hong Kong Island	Head Office	45 Des Voeux Road Central
form. If it is a joint application, the account name		Kennedy Town Branch	28 Catchick Street
must be the same as the name of the first-named

applicant;	Kowloon	Mongkok Branch	B/F CMB Wing Lung Bank Centre,
‧ be made payable to "BANK OF CHINA (HONG			636 Nathan Road
KONG) NOMINEES LIMITED - HENLIUS
	Tsim Sha Tsui Branch	4 Carnarvon Road
BIOTECH PREFERENTIAL OFFER";
‧ be crossed "Account Payee Only"; and	New Territories	Tsuen Wan Branch	251 Sha Tsui Road

‧ not be post-dated.	5. This Application Form can be lodged at these times:
Your application may be rejected if your cheque:

‧ does not meet all these requirements; or	Thursday, 12	September 2019	-	9:00 a.m. to 5:00 p.m.
‧ is dishonoured on its first presentation.	Friday, 13	September 2019	-	9:00 a.m. to 5:00 p.m.
If you pay by banker's cashier order, the cashier
order must:	Monday, 16	September 2019	-	9:00 a.m. to 5:00 p.m.
‧ be in Hong Kong dollars;	Tuesday, 17	September 2019	-	9:00 a.m. to 12:00 noon

‧ be issued by licensed banks in Hong Kong, and have	6. The latest time for lodging your application is 12:00 noon
your name certified at the back of the order by a
on Tuesday, 17 September 2019 or, if the application lists
person authorised by the bank. The name on the back

Sample
of the order and the name on this Application Form	are not open on that day,版then by 12:00 noon on the next
must be the same. If it is a joint application, the name	day the lists are open. The application lists will be open
at the back of the order must be the same as the name	b tw	n 11:45 a.m. and 12:00 noon on that day, subject
of the first-named applicant;		on y to w ather conditions. The application lists will not
‧ be made payable to "BANK OF CHINA (HONG	op n if th re is:
KONG) NOMINEES LIMITED - HENLIUS	‧ a typhoon warning signal 8 or above;
BIOTECH PREFERENTIAL OFFER";	‧ an	xtr me condition caused by a super typhoon
‧ be crossed "Account Payee Only"; and	樣
‧ not be post-dated.		announced by the Government of the Hong Kong
			Special Administrative Region; or
Your application is liable to be rejected if your cheque	‧ a "black" rainstorm warning
or banker's cashier order does not meet all these	in force in Hong Kong at any time between 9:00 a.m.
requirements.			and 12:00 noon on Tuesday, 17 September 2019. Instead
4. Fold this Application Form once and lodge it to one of	they will be open between 11:45 a.m. and 12:00 noon on
the collection boxes at any of the following branches of	the next business day which does not have either of those
Bank of China (Hong Kong) Li	ited and CMB Wing	warnings and/or extreme condition in force at any time
Lung B nk Li	ited:
	between 9:00 a.m. and 12:00 noon. Business day means

Bank of China (Hong Kong) Li	ited	a day that is not a Saturday, Sunday or public holiday in
District	Br nch N e	Address	Hong Kong.
Hong Kong Isl nd	Des Voeux Ro d	111-119 Des Voeux Road West,	7. The right is reserved to present all or any remittances
	West Br nch	Hong Kong	for payment. However, your cheque or banker's
	Chai Wan Branch	Block B, Walton Estate, 341-343	cashier order will not be presented for payment
		Chai Wan Road, Chai Wan, Hong	before 12:00 noon on Tuesday, 17 September 2019.
		Kong	You will not be given a receipt for your payment.
Kowloon	Telford Plaza Branch	Shop Unit P2-P7, Telford Plaza,
The Company will retain any interest accrued on
		No.33 Wai Yip Street, Kowloon	your application monies. The right is also reserved
		Bay, Kowloon
		to retain any Share certificate(s) and/or any surplus
	Olympian City Branch	Shop 133, 1/F, Olympian City 2, 18
	application money(ies) or refunds pending clearance
		Hoi Ting Road, Kowloon
		of your cheque or banker's cashier order.
New Territories	Metro City Branch	Shop 209, Level 2, Metro City

		Phase 1, Tseung Kwan O, New
		Territories
	Ma On Shan Plaza Branch	Shop 2103, Level 2, Ma On Shan
		Plaza, Sai Sha Road, Ma On Shan,
		New Territories

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

Shanghai Henlius Biotech, Inc.

上海復宏漢霖生物技術股份有限公司

（於中華人民共和國註冊成立的股份有限公司）

	全球發售
申請條件			不管招股章程或本申請表格的任何其他
除另有指明外，此等條件所用詞彙具備招股章程			條文或藍表eIPO 服務的條款及條件，倘
所賦予的相同涵義。			本公司全權酌情信納有關交易獲豁免或
甲. 申請人資格			毋須遵守導致上述限制的法例或規例，
1.	閣下（申請人）及閣下為其利益而提出
		則本公司保留權利允許任何復星醫藥H

	申請的任何人士必須為合資格復星醫藥		樣
	H 股股東並年滿18 歲。			股股東接納其預留股份的保證配額。
2.	如閣下屬商號，則須以個別成員的名		5.	聯名申請人的總數不可超過四人。
	義而非以商號的名義作出申請。	乙.	分配預留股份
3.	如閣下屬法人團體，申請表格必須加		倘有效申請之預留股份數目少於或相等
				版
	蓋公司印鑑（附有公司名稱）並由獲正式		於	閣下之保證配額，在受本申請表格所
	授權的高級職員簽署，並須註明其代表		載條款及條件的規限下，且假設優先發售
	身份。		之條件已達成，則申請將會獲全數接納。
4.	除上市規則及聯交所發出的指引信許可		倘申請的預留股份數目少於閣下的保證配
	的情況或聯交所已授予的任何相關豁免		額，閣下必須申請本申請表格內數目及款
	批准外，倘若閣下或（香港結算代理人
		項一覽表所列的其中一個數目並支付相應款
	除外）閣下為其利益而提出申請的任何
		額（香港結算代理人除外）。倘閣下擬申請
	人士為下列人士，則不得申請認購任何
		並非藍色申請表格申請保證配額表中載列的
	預留股份：
		其中一個保證配額數目，閣下必須用藍表
	‧ 本公司及╱或任何附屬公司之股份
		eIPO 申請。倘	閣下擬申請保證配額以外的
	的現有實益擁有人；
		超額預留股份，則須填妥並簽署申請超額預
	‧ 本公司及╱或本公司任何附屬公司
		留股份之藍色申請表格，並單獨匯款足額支
	之董事或最高行政人員；
	‧ 上述任何人士的聯繫人；		付所申請超額預留股份的應付股款，或透過
	‧ 本公司的關連人士或於緊隨全球發		www.eipo.com.hk使用藍表eIPO 服務遞交
	售完成後將成為本公司關連人士的		申請。倘申請的預留股份數目多於閣下的
	人士；或		保證配額，相關保證配額的申請將獲全數接
	‧ 不合資格復星醫藥H 股股東。		納，但超額預留股份的申請則只在有足夠的
	不合資格復星醫藥H 股股東指於記錄日
		可用預留股份的情況下方獲接納。倘預留股
	期登記地址位於香港以外司法權區或據
		份的超額申請：
	復星醫藥另行得悉為香港以外司法權區
		(i)	少於可用預留股份，則可用預留股份將
	居民的復星醫藥H 股股東，復星醫藥及

Sample本公司董事根據彼等就該等股東所作出	首先悉數分配以滿足該等預留股份的超
	的查詢，考慮到有關復星醫藥H 股股東			額申請，而其後將由聯席代表酌情分配
	所處有關司法權區法律的限制或該司法			至國際發售；
	權區有關監管機構或證券交易所的規定		(ii) 與可用預留股份相同，則可用預留股份
	後，認為將彼等排除在優先發售之外屬			將悉數分配以滿足該等預留股份的超額
	必要或合宜者。			申請；或

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

多於可用預留股份，則可用預留股份將人）代表委託閣下作為代理人或代名人的按與香港公開發售超額認購情況下常用每名人士：

的分配基準一致的分配基準分配，當中	‧	指示及授權本公司及╱或聯席代表（或
認購額較細的申請將獲較高的分配百分		彼等各自的代理或代名人），根據本公
比。倘滿足超額申請後有任何剩餘的股		司章程細則的規定，代表閣下簽立任
份，有關股份將由聯席代表酌情重新分		何過戶表格、成交單據或其他文件，並
配至國際發售。為補足股份的零碎持有		代表	閣下辦理其他一切必需手續，以
量至一手完整持有量而作出的任何超額		完成以閣下名義登記閣下獲分配的
申請將不會獲得優先處理。		任何預留股份，或以其他方式令招股章
除上述者外，優先發售將不受國際發售與香		程及本申請表格所述的各項安排落實生
港公開發售之間的回補安排所限。未附帶正		效；
確金額申請款項的任何申請將視為完全無效	‧	承諾簽署所有文件及辦理所有必需手
	續，以便可按本公司章程細則的規定，
且不會向有關申請人配發任何預留股份。
	讓	閣下登記成為	閣下獲分配的預留
除透過藍表eIPO 服務(www.eipo.com.hk) 或
	股份的持有人；
藍色申請表格申請預留股份外，合資格復星
‧	聲明、保證及承諾	閣下明白預留股份
醫藥H 股股東亦可使用白色或黃色申請表格
	並無亦不會根據《美國證券法》進行登
或透過中央結算系統向香港結算發出電子認
		版
購指示或透過白表eIPO 服務作出一份香港		記，而（香港結算代理人除外）閣下
Sample	或	閣下作為其代表或為其利益購買預
發售股份申請。		留股份的任何其他人士身處美國境外（定
合資格復星醫藥H 股股東根據香港公開發售		義見S 規例）及S 規例第902 條第(h)(3) 段
使用白色或黃色申請表格或向香港結算發出		所述的人士；
電子認購指示或透過白表eIPO 服務申請香	‧樣確認閣下提出本申請時僅依賴招股章
港發售股份，在配額或分配方面並無優先		程所載的資料及陳述，而除招股章程任
權。		何補充文件所載者外，將不會依賴任何
合資格復星醫藥H 股股東可按其各自於記錄		其他資料或陳述；
日期每持有132 股復星醫藥H 股股份的完整	‧	同意本公司、有關人士或橙表及藍表
倍數獲發保證配額一個預留股份的基準提出		eIPO 服務供應商現時及日後均毋須對並
申請。於記錄日期持有少於132 股復星醫藥		非載於招股章程（及其任何補充文件）的
H 股的合資格復星醫藥H 股股東將不會享有		任何資料及陳述負責；
預留股份的保證配額，但仍有權透過申請超
‧	同意（在不損害閣下可能擁有的任何其
額預留股份參與優先發售。
	他權利的情況下）本申請一經接納，即不
丙. 補充資料
	得因無意的失實陳述而撤銷；
倘刊發招股章程的任何補充文件，已提交
‧ （如申請由代理代表閣下提出）保
申請的申請人可能會或可能不會（視乎補充		證	閣下已向閣下的代理有效及不可
文件所載資料而定）獲通知彼等須確認其申		撤回地授予一切必需的權力及授權以提
請。如申請人已獲通知但未有根據獲通知的		出本申請；
程序確認彼等的申請，則所有未經確認申請	‧ （如	閣下為他人的代理）保證已向實益
將會無效。受上文所規限，申請一經提交即		擁有人作出合理查詢，證實本申請乃為
不得撤銷，而申請人將視為根據已按經補充		該人士利益以藍色申請表格而作出的唯
的招股章程提出申請。		一申請，而閣下已獲正式授權，以該
丁. 填交本申請表格的效用		人士代理的身份簽署本申請表格；
本申請表格一經填妥及提交，即表明閣下	‧	同意	閣下的申請一經接納，閣下的申
（及如屬聯名申請人，即閣下與聯名申請		請將以本公司公佈的優先發售結果為證
人共同及個別）本身或（如作為代理人或代名		明；

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

‧ 保證本申請所載資料屬真實及準確；	‧	確認閣下知悉招股章程所述有關預留
‧ 同意向本公司、H 股證券登記處、收款		股份的優先發售限制；
銀行、有關人士及橙表及藍表eIPO 服務	‧	明白本公司及聯席代表將依賴此等聲明
供應商披露彼等所需關於閣下或（香港		及陳述，以決定是否就閣下提出的申
結算代理人除外）閣下為其利益提出申		請向閣下分配任何預留股份；
請的人士的任何個人資料；		‧ 倘香港境外任何地方的法律適用於閣
				版
‧ 保證在提出申請時，閣下或	閣下可能		下的申請，則	閣下同意並保證，閣下
代其行事之任何人士為合資格復星醫藥		已遵守所有該等法律，而本公司或有關
H 股股東；			人士概不會因接納	閣下購買任何預留
‧ 聲明、保證及承諾，在提出本申請		股份的要約，或因	閣下在招股章程所
時，閣下及╱或（香港結算代理人除		載條款及條件項下的權利與責任所產生
外）閣下可能代其行事之任何人士並非		的任何行動而觸犯香港境外任何法律；
		樣
關連人士，亦並非將在緊隨全球發售完成	‧	向本公司（並為各股東的利益）表示同意
後成為本公司關連人士的人士，而閣下		（及從而使本公司（為其本身並代表各股
及╱或（香港結算代理人除外）閣下可		東）藉其接納全部或部分本申請而視為已
能代其行事之任何人士認購預留股份並非		同意）（及（如適用）向發出電子認購指示
直接或間接由本公司的關連人士提供資		的各中央結算系統參與者表示同意），以
Sample	及本公司向各股東表示同意，遵守及符
金，且閣下及╱或（香港結算代理人除		合香港法例第622 章公司條例、香港法
外）閣下可能代其行事之任何人士並非		例第32 章公司（清盤及雜項條文）條例及
根據本公司關連人士的指示作出預留股份		本公司章程細則；
的是次認購；		‧ 向本公司及各股東表示同意股份可由該
‧ 同意閣下的申請、接納申請及由此而		股東自由轉讓；及
產生的合約均受香港法例管轄，並按其	‧	明白本公司及有關人士均有權依賴閣
詮釋；			下於本申請作出的任何保證、陳述或聲
‧ 承諾並同意接納所申請的預留股份，		明。倘為聯名申請人提出的申請，表示
或閣下根據申請所獲分配的任何較少		由聯名申請人提出、作出或承擔或須履
數目；			行的所有保證、陳述、聲明及責任，均
‧ 授權本公司將閣下的姓名╱名稱列		視為由各申請人共同及個別地提出、作
入H 股股份登記冊，作為閣下獲分配
	出及承擔及須履行。	閣下如作出虛假
的任何預留股份的持有人，及根據本公
	聲明可被檢控。
司章程細則規定的本公司股東名冊內，
除另有註明外，閣下必須以英文填妥本申
並按本申請表格上所示地址以普通郵遞
請，而閣下或（倘為聯名申請人）各聯名申
方式寄發任何股票（如適用）及╱或任何
請人必須親筆簽署本申請（不得以個人印章
退款支票（如適用予閣下或（如為聯名
代替），否則申請可被拒絕受理。
申請人）本申請表格內排名首位的申請
戊. 授權書
人，郵誤風險概由閣下自行承擔（除非
倘	閣下的申請由根據授權書獲正式授權的
如閣下申請1,000,000 股或以上預留股
人士提出，本公司及聯席代表（作為本公司的
份，則可親自領取閣下的退款支票及
代理）可酌情按彼等認為合適的任何條件（包
股票（如適用））；
	括出示代表的授權證明文件）接納申請。本
‧ 同意任何收款銀行，而不限於	閣下遞
公司及聯席代表（作為本公司的代理）將可全
交申請表格的銀行，可處理	閣下的申
權酌情決定拒絕或接納任何申請的全部或部

請，包括寄發退款支票（如有）；分，而毋須提供任何理由。

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

己. 釐定發售價	寄往		閣下申請表格所示地址，郵誤風險由閣
預期發售價於二零一九年九月十七日（星期二）或	下承擔。
前後釐定。申請人須繳付每股發售股份57.80 港	本公司不會發出臨時所有權文件。
元（多繳款項可予退還）的最高發售價，另加1%	股票僅會於全球發售在所有方面成為無條件及招
經紀佣金、0.0027% 證監會交易徵費及0.005% 聯	股章程「包銷」一節所述的包銷協議終止權利並無
交所交易費。倘若本公司與聯席代表（代表包銷	行使的情況下，方會於二零一九年九月二十五日
商）並無於二零一九年九月二十四日（星期二）或	份：			版
（星期三）上午八時正成為有效的所有權憑證。
之前協定發售價，全球發售將不會進行並將告失	已繳付的申請款項將不獲發收據。倘發售價低
效。		於	閣下支付的每股預留股份價格，多繳的申請
預留股份的配發	款項（包括多繳款項應佔的經紀佣金、證監會交
在本申請表格及招股章程載列的條款及條件規限	易徵費及聯交所交易費）將不計利息退還予閣
下，預留股份將於截止辦理申請登記後配發。	下。投資者在收到股票前或在股票成為有效前買
			樣
本公司預期於二零一九年九月二十四日（星期二）賣股份，須自行承擔全部風險。
在《南華早報》（英文）、《香港經濟日報》（中文）、	閣下不獲配發預留股份的情況
聯交所網站(www.hkexnews.hk) 及本公司網站	閣下可能基於下列任何理由而不獲分配預留股
(www.henlius.com) 公佈發售價、國際發售的踴
躍程度、香港公開發售及優先發售的認購水平以	1. 倘	閣下的申請被撤回：
及香港發售股份及預留股份的分配基準。香港公
開發售及優先發售的分配結果及成功申請人的香	填妥及遞交申請表格或向香港結算或利用藍表
IPO 服務發出電子認購指示後，即表示閣下
港身份證╱護照╱香港商業登記號碼亦同於上述
網站公佈。	同意不得於開始辦理申請登記後第五日（就此而
言，不包括任何非營業日）屆滿或之前撤回申請
倘	閣下成功申請認購（全部或部分）預留股份
或香港結算代理人代表閣下提出的申請，除非
如	閣下申請認購1,000,000 股或以上預留股
根據香港法例第32 章公司（清盤及雜項條文）條
份，且已提供本申請表格所規定全部資料，閣
例第40 條對招股章程負責的人士根據該條發出公
下可於二零一九年九月二十四日（星期二）或本公
告，免除或限制該人士對招股章程的責任。此協
司在報章上公佈的其他地點或日期的上午九時正
議將成為本公司訂立的附屬合約，並在閣下遞
至下午一時正，親身前往香港中央證券登記有限
交本申請表格時即具約束力。該附屬合約的代價
公司（地址為香港灣仔皇后大道東183 號合和中
為本公司同意，除按招股章程所述任何一項程序
心17 樓1712-1716 室）領取閣下的退款支票及
外，不會於二零一九年九月二十四日（星期二）或
╱或股票。
之前向任何人士提呈發售任何預留股份。
如	閣下為個人申請人並合資格親身領取，閣
閣下的申請一經接納，則不得撤回。就此而言，
下不得授權任何其他人士代領。如閣下為公司
在公告公佈分配結果即屬接納未遭拒絕的申請，
申請人並合資格親身領取，閣下的授權代表須
而倘有關分配基準受若干條件規限或訂定以抽籤
攜同蓋上公司印鑑的授權書領取。
個人申請人及授權代表領取時均須出示香港中央	方式分配，則申請獲接納與否將分別視乎能否達
證券登記有限公司接納的身份證明文件。	成有關條件或抽籤的結果而定。
如	閣下並無在指定領取時間內親身領取退款支	2. 本公司、聯席代表以及彼等各自的代理或代
		名人可全權酌情決定拒絕或接納閣下的申
票及Sample╱或股票，有關退款支票及╱或股票將會立
刻以普通郵遞方式寄往本申請表格所示地址，郵	請：
誤風險由閣下承擔。	本公司及聯席代表或彼等各自的代理或代名
如	閣下申請認購1,000,000 股以下預留股	人可全權酌情決定拒絕或接納任何申請，或
份，閣下的退款支票及╱或股票將於二零一九	僅接納任何部份申請，而毋須就任何拒絕或
年九月二十四日（星期二）或之前以普通郵遞方式	接納提供任何理由。

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

3.	倘預留股份配發作廢：		‧ 本公司及聯席代表及其各自的代理或代
	倘上市委員會在下列期間未批准股份上市，		名人行使酌情權，決定拒絕或接納任何
	則配發予閣下的預留股份將告作廢：		申請，或僅接納部分申請。拒絕或接納
	‧ 由截止辦理申請登記日期起計三星期		申請毋須給予任何理由。
	內；或	5. 倘閣下使用藍色申請表格申請保證配
	‧ （倘聯交所上市委員會在截止辦理申請登		額，閣下可申請相等於或少於乙欄所列數目
	記日期後三星期內通知本公司延長有關		的保證配額的預留股份。倘閣下擬申請少
	期間）由截止辦理申請登記日期起計最多		於閣下保證配額的預留股份，閣下必須申
	六星期內。		請藍色申請表格一覽表所列數目之一，並相
4.	在下列情況下，閣下將不獲任何配發：		應付款（香港結算代理人除外）。
	‧ 本申請表格並無按照本申請表格所載指		閣下須就保證配額填妥並簽署藍色申請表
	示填妥；		格，並提交一張支票（或銀行本票），金額須
	‧ 本申請表格並無妥為簽署（僅接受親筆簽		樣
		為乙欄所印列的確切金額或藍色申請表格一
	名）（倘為聯名申請，則未經全部申請人		覽表所載的相應應付金額。倘閣下擬申請
	簽署）；		並非藍色申請表格申請保證配額表中載列的
	‧ 就法人團體申請人而言，本申請表格未		其中一個保證配額數目，閣下必須使用藍表
	經獲授權的高級職員妥為簽署（僅接受親			版
	筆簽名）或未加蓋公司印鑑；		eIPO 申請。倘閣下擬申請保證配額以外的
		超額預留股份，則須填妥並簽署申請超額預
	Sample
	‧ 支票╱銀行本票╱本申請表格有缺陷；		留股份之藍色申請表格，並單獨匯款足額支
	‧ 本申請表格並無就各份保證配額的申請		付所申請超額預留股份的應付股款，或透過
	及預留股份的超額申請附有支票╱銀行		www. ipo.com.hk使用藍表eIPO 服務遞交申
	本票或附有超過一張支票╱銀行本票；		請。
	‧ 支票╱銀行本票並無預印賬戶名稱或賬	6.	倘閣下使用藍色申請表格申請超額預留股
	戶名稱未經開具銀行證明；		份，閣下必須申請藍色申請表格一覽表所
	‧ 支票╱銀行本票並非自香港的港元銀行		列超額預留股份數目之一，並相應付款（香
	賬戶開出；		港結算代理人除外）。閣下須就超額預留
	‧ 支票╱銀行本票的抬頭人並非「中國銀行		股份填妥並簽署藍色申請表格，並提交一張
	( 香港) 代理人有限公司－復宏漢霖生物		獨立開出的支票（或銀行本票）支付確切金
	技術優先發售」；		額。倘閣下擬申請並非藍色申請表格申請
	‧ 支票並無劃線註明「只准存入抬頭人賬
		超額預留股份表中載列的其中一個保證配額
	戶」；
		數目，閣下必須使用藍表eIPO 申請。
	‧ 支票為期票；
	7.	倘閣下擬同時申請保證配額的預留股份及
	‧ 申請人未正確付款或申請人以支票或銀
	行本票付款但支票或銀行本票於首次過		超額預留股份，閣下必須同時提交保證配
		額的藍色申請表格及超額預留股份的藍色申
	戶時不獲兌現；
		請表格。每份藍色申請表格必須附上一張獨
	‧ 申請人名稱╱聯名申請的排名首位申請
		立開出的支票（或銀行本票）支付確切金額。
	人名稱並非預印名稱或並非由銀行授權
	退回款項
	人士在支票或銀行本票背書的名稱相
	若	閣下未獲分配任何預留股份或申請僅部分獲
	同；
	接納，本公司將不計利息退回閣下的申請股款
	‧ 本申請表格所提供申請資料的更改未獲
	申請人簽署授權；	（包括相關的1% 經紀佣金、0.0027% 證監會交易
	‧ 本公司相信如接納申請，會違反收取本	徵費及0.005% 聯交所交易費）或其中適當部分。
	申請表格或申請人地址所在司法權區的	如發售價低於最高發售價，本公司將不計利息
	適用證券或其他法例、規則或規例；或	退回多收申請股款（包括相關的1% 經紀佣金、

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

0.0027% 證監會交易徵費及0.005% 聯交所交易	2.	目的
費）。有關退款程序載於招股章程「如何申請香港		證券申請人及持有人的個人資料可以作以下
發售股份及預留股份」一節「H. 發送╱領取股票╱		目的使用、持有及╱或保存（以任何方式）：
電子退款指示╱退款支票」。		‧ 處理	閣下的申請及退款支票（如適用）
閣下提供給香港中央證券登記有限公司的資訊的			及核實是否符合本申請表格及招股章程
		載列的條款和申請程序，以及公佈預留
有關影響
				版

香港中央證券登記有限公司和其有關連的法人團			股份的分配結果；
	‧ 遵守香港及其他地區的一切適用法律及
體、董事、高級人員、僱員及代理人（「代表」）在
		法規；
法律所容許的最大限度內明確卸棄及免除在任何
	‧ 登記新發行證券或以證券持有人的名義
方面與申請人或代表申請人在此文件提供的或與
		（包括以香港結算代理人名義（如適用））
此文件或在此文件下提供的任何服務相關的任何
		轉讓或受讓證券；
性。
		樣
資料，或任何申請人或代表申請人提供與此文件		‧ 存置或更新本公司證券持有人的名冊；
或在此文件下提供的任何服務相關的任何其它書		‧ 核實或協助核實簽名、任何其他核證或
面或口頭通訊，有關或相關由申請人或任何其他			交換信息；
人士或實體所遭受或招致不論如何造成的任何損		‧ 確立本公司證券持有人的受益權利，如
失或損害的任何法律責任。此包括，但不限於，			股息、供股和紅股等；
	Sample
該等資料中不論如何造成的任何錯誤或遺漏，或		‧	分發本公司及其附屬公司的通訊；
代表或任何其他人士或實體對該等資料或任何該		‧ 編製統計信息和證券持有人資料；
等資料的文件記錄、影像、記錄或複製品作出的		‧ 根據香港或其他地區的法律、規則或規
任何依據，或其準確性、完整性、合時性或可靠			例進行披露（無論法定或其他規定）；

			‧ 披露有關信息以便就權益提出申索；及
個人資料		‧ 與上述有關的任何其他附帶或相關目的
		及╱或使本公司及H 股證券登記處能履
個人資料收集聲明
		行對證券持有人及╱或監管機構承擔的
香港法例第486 章《個人資料（私隱）條例》（「條
		責任及╱或證券持有人不時同意的任何
例」）的主要條款已於一九九六年十二月二十日在
		其他目的。
香港生效。此項個人資料收集聲明是向香港發售
3.	轉交個人資料
股份申請人和持有人說明有關本公司及其H 股證
券登記處在個人資料和條例方面的政策和慣例。		本公司及H 股證券登記處持有關於證券申請
	人及持有人的個人資料將會保密，但本公司
1. 收集閣下個人資料的原因
	及H 股證券登記處可以在達到上述目的或當
證券申請人或證券登記持有人以自己的名義
	中任何目的的必要的情況下，作出彼等認為
申請認購證券或轉讓或受讓證券時或尋求H
	必要的查詢以確認個人資料的準確性，尤其
股證券登記處的服務時，須不時向本公司及
	彼等可向或從下列任何及全部人士和實體或
其H 股證券登記處提供其最近的準確個人資
	與下列任何及全部人士和實體互相披露、取
料。未能提供所要求的資料可能導致閣下
	得或轉移（無論在香港境內或境外）證券申請
申請證券被拒或延遲，或本公司或其H 股證
	人及持有人的個人資料：
券登記處無法落實轉讓或提供服務，亦可能
	‧ 本公司或彼等各自指定的代理，如財務
妨礙或延遲登記或轉讓閣下成功申請認購
		顧問和收款銀行；
的預留股份及╱或發送股票及╱或發送閣
	‧ 香港結算及香港結算代理人，彼等將會
下應得的退款支票。
		就中央結算系統的運作使用個人資料（倘
如提供的個人資料有任何錯誤，證券持有人			申請人要求將預留股份記存於中央結算
須立即通知本公司和H 股證券登記處。			系統）；

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

	‧ 任何向本公司及╱或H 股證券登記處提	外）。倘閣下擬申請並非藍色申請表格申
	供與其各自業務營運有關的行政、電	請保證配額表中載列的其中一個保證配額數
	訊、電腦、付款或其他服務的代理、承	目，閣下必須使用藍表eIPO 申請。倘閣
	包商或第三方服務供應商；		下擬申請保證配額以外的超額預留股份，則
	‧ 聯交所、證監會及香港或其他地區的任	須填妥並簽署申請超額預留股份之藍色申請
	何其他法定、監管或政府機關；及	表格，並單獨匯款足額支付所申請超額預留
	‧ 證券持有人與其進行或擬進行交易的任	股份的應付股款，或透過www.eipo.com.hk
	何其他人士或機構，如彼等的銀行、律	使用藍表eIPO 服務遞交申請。倘閣下擬
	師、會計師或股票經紀等。		申請相等於閣下保證配額的預留股份數
4.	保留個人資料		目，閣下應：(i) 填妥並簽署申請表格；及
	本公司及H 股證券登記處將按收集個人資料	(ii) 提交一張支票（或銀行本票），金額須為申
	所需的用途保留證券申請人及持有人的個人	請表格乙欄所印列確切金額。
	資料。無需保留的個人資料將會根據條例銷	倘	閣下使用藍色申請表格申請超額預留
	毀或處理。		股份，閣下應：(i) 填寫所申請的超額預留
5.	查閱和更正個人資料		股份數目及應付金額（申請表格一覽表所載
	條例規定，證券申請人及持有人有權確定	者）；(ii) 填妥並簽署申請表格；及(iii) 提交
	本公司或H 股證券登記處是否持有其個人資	一張獨立開出的支票（或銀行本票），金額須版
	料，並有權索取有關該資料的副本並更正任	為	閣下在申請表格填寫的相同金額。閣
	何不準確資料。根據條例，本公司和H 股證	下擬申請的超額預留股份數目必須為申請表
	券登記處有權就處理任何查閱資料的要求收	格申請超額預留股份一覽表所載數目之一
	取合理的費用。所有查閱資料或更正資料的	（香港結算代理人除外）。倘閣下擬申請並
	非藍色申請表格申請超額預留股份表中載列
	要求或查詢有關政策及慣例以及持有資料種
	樣

	類的要求，均須按招股章程「公司資料」一節	的其中一個保證配額數目，閣下必須使用
	藍表eIPO 申請。
	所披露或不時按適用法例獲知會的註冊地址
	請填妥並簽署申請表格。僅接納親筆簽名。
	送交本公司公司秘書或送交H 股證券登記處 2.
	私隱監察人員。	3.	支票或銀行本票須緊釘於表格。閣下必須
		以一張支票或一張銀行本票支付保證配額的
如	閣下簽署本申請表格，即表示	閣下同意上
申請款項及╱或以一張支票或一張銀行本票
述各項。
	支付超額預留股份的申請款項。每份申請均
申請程序
	須附帶一張獨立支票或銀行本票。
除使用藍色申請表格外，閣下亦可透過
如以支票繳付款項，該支票必須：
www.eipo.com.hk利用藍表eIPO 服務申請預留
‧ 為港元支票；
股份並使用繳費靈或網上銀行付款方法付款。
‧ 由香港的港元銀行賬戶開出；
1. 倘閣下使用藍色申請表格申請保證配
‧ 顯示閣下的賬戶名稱，而該賬戶名必
	額，閣下可申請相等於或少於申請表格
		須預印於支票，或由有關銀行授權人在
	乙欄所列數目的保證配額的預留股份。
		該支票背面簽署證明賬戶名。該賬戶名
	倘閣下擬申請少於閣下保證配額的預
		必須與閣下於本表格上的姓名相同。
	留股份，閣下必須申請藍色申請表格申請
		如屬聯名申請，則賬戶名稱必須與排名
	保證配額表中載列的其中一個保證配額數
		首位申請人的名稱相同；
	Sample

	目，閣下應：(i) 填寫所申請的預留股份數	‧ 註明抬頭人為「中國銀行( 香港) 代理人
	目及應付金額（申請表格一覽表所載者）；
		有限公司－復宏漢霖生物技術優先發
	(ii) 填寫並簽署申請表格；及(iii) 提交一張
		售」；
	支票（或銀行本票），金額須為	閣下在申
	‧ 劃線註明「只准存入抬頭人賬戶」；及

請表格填寫的相同金額（香港結算代理人除 ‧ 不得為期票。

藍表

閣下如為合資格復星醫藥H 股股東且透過www.eipo.com.hk 進行網上申請時遇到困難，請使用本申請表格

下列情況將導致申請可能不獲受理：	5.	閣下可於下列時間遞交本申請表格：
‧ 支票不符合所有上述規定；或		二零一九年九月十二日（星期四）－上午九時正至下午五時正
‧ 支票首次過戶時不獲兌現。
	二零一九年九月十三日（星期五）－上午九時正至下午五時正
如以銀行本票繳付款項，該本票必須：
	二零一九年九月十六日（星期一）－上午九時正至下午五時正
‧ 為港元；
		二零一九年九月十七日（星期二）－上午九時正至中午十二時正
‧ 由香港持牌銀行發出，並由發出本票銀

行的授權人在本票背面簽署證明閣下	6.	遞交申請的截止時間是二零一九年九月十七
						版
姓名。本票背面所顯示姓名須與本申請		日（星期二）中午十二時正，如該日並無開
表格所填寫的姓名相同。如屬聯名申		始登記認購申請，則為下一日開始登記認購
請，本票背面所示姓名必須與排名首位		申請的中午十二時正。本公司將於當日上午
申請人的姓名相同；			十一時四十五分至中午十二時正期間登記認
‧ 註明抬頭人為「中國銀行( 香港) 代理人		購申請，惟須視乎當日天氣情況而定。如下
有限公司－復宏漢霖生物技術優先發		列警告信號在二零一九年九月十七日（星期
售」；
			二）上午九時正至中午十二時正期間任何時
‧ 劃線註明「只准存入抬頭人賬戶」；及
	間在香港懸掛，將不會登記申請：
‧ 不得為期票。
		‧ 八號或以上颱風警告信號；
如閣下的支票或銀行本票不符合上述所有
	‧ 香港特別行政區政府公佈由超強颱風引
規定，則	閣下的申請可能遭拒絕受理。

Sample	起的極端環境；或
4. 將本申請表格對摺一次，然後投入中國銀行		‧ 「黑色」暴雨警告信號。
（香港）有限公司及招商永隆銀行有限公司的		如在該日的下一個營業日上午九時正至中午
下列任何一間分行的收集箱：		十二時正期間任何時間並無懸掛上述任何警
中國銀行（香港）有限公司			樣
地區	分行名稱	地址		告及╱或出現極端環境，申請認購登記將在
香港島	德輔道西分行	香港德輔道西111-119號		該下一個營業日上午十一時四十五分至中午
	柴灣分行	香港柴灣道341-343 號宏德居		十二時正期間開始。營業日指星期六、星期
		B 座		日或香港公眾假期以外的日子。
九龍	德福廣場分行	九龍灣偉業街33 號德福廣場	7.	本公司保留將閣下的一切或任何股款過戶
		P2-P7號舖		的權利，然而，閣下的支票或銀行本票不
	奧海城分行	九龍海庭道18 號奧海城二期		會於二零一九年九月十七日（星期二）中午
		一樓133 號		十二時正前過戶。	閣下不會就已繳付款項

新界	新都城分行	新界將軍澳新都城一期二樓		獲發收據。本公司將保留閣下的申請款項
		209 號		的任何應得利息。在閣下的支票或銀行本
	馬鞍山廣場分行	新界馬鞍山西沙路馬鞍山廣
		票過戶前，本公司亦有權保留任何股票及╱
		場L2 層2103 號
			或任何多收的申請款項或退款。
招商永隆銀行有限公司

地區	分行名稱	地址
香港島	總行	德輔道中45 號
	堅尼地城分行	吉席街28 號
九龍	旺角分行	彌敦道636 號招商永隆銀行中
		心地庫
	尖沙咀分行	加拿分道4 號
新界	荃灣分行	沙咀道251 號

Attachments

Original document
Permalink

Disclaimer

HKEx - Hong Kong Exchanges and Clearing Ltd. published this content on 12 September 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2019 22:56:06 UTC

Market Closed - Hong Kong S.E. Other stock markets 04:09:09 2024-04-25 am EDT			5-day change	1st Jan Change
246.8 ^HKD	+3.26%		+12.90%	-7.91%

11:14am	Nomura Adjusts Hong Kong Exchanges And Clearing's Price Target to HK$324.31 From HK$322.28, Keeps at Buy	MT
07:09am	HKEX Appoints Chairman	MT

Nomura Adjusts Hong Kong Exchanges And Clearing's Price Target to HK$324.31 From HK$322.28, Keeps at Buy	05:14am	MT
HKEX Appoints Chairman	01:09am	MT
Hong Kong bourse operator names Carlson Tong as new chairman	Apr. 24	RE
Hong Kong Exchanges and Clearing Limited Announces Board Changes	Apr. 24	CI
HKEX's Q1 Profit Falls 13% as Revenue Slides 6%	Apr. 24	MT
HKEX's Profit Falls for Second Straight Quarter on Weak Trading, Listings -- Update	Apr. 24	DJ
HKEX's Net Profit Declines for Second Straight Quarter	Apr. 24	DJ
Hong Kong bourse operator's Q1 profit down 13% on weaker listings, trading	Apr. 24	RE
Hong Kong Exchanges and Clearing Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Hong Kong Exchanges and Clearing Limited Announces Executive Changes	Apr. 17	CI
LME bans Russian-origin metal after UK, US impose new sanctions	Apr. 13	RE
Fresh Capital from IPOs in Hong Kong Falls 30% in Q1	Apr. 10	MT
LME plans to list Saudi port as a copper and zinc delivery point	Mar. 19	RE
Nomura Adjusts Hong Kong Exchanges and Clearing’s Price Target to HK$322.28 From HK$324.78, Keeps at Buy	Mar. 19	MT
Hong Kong stock exchange poised to name Carlson Tong as new chair, sources say	Mar. 07	RE
Nomura Adjusts Hong Kong Exchanges and Clearing’s Price Target to HK$324.78 From HK$332.40, Keeps at Buy	Mar. 01	MT
Hong Kong Exchanges and Clearing Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Transcript : Hong Kong Exchanges and Clearing Limited, 2023 Earnings Call, Feb 29, 2024	Feb. 29
HKEX profit up in 2023 despite weak fourth quarter	Feb. 29	AN
Hong Kong Exchanges and Clearing Limited Announces Management Changes, Effective 1 March 2024	Feb. 29	CI
HKEX's Earnings Took a Blow as Slower China Growth Hit Markets -- Update	Feb. 29	DJ
HKEX's 2023 Attributable Profit Rises 18%; EPS Misses Estimates	Feb. 29	MT
Hong Kong exchange's 2023 profit misses forecast as new listings, trading income sags	Feb. 28	RE
HKEX's Fourth-Quarter Net Profit Declines Amid Poor Market Sentiment	Feb. 28	DJ
Hong Kong exchange's 2023 profit rises 18% on investment income gains	Feb. 28	RE

	1st Jan change	Capi.
HONG KONG EXCHANGES AND CLEARING LIMITED	-7.91%	38.59B
INTERCONTINENTAL EXCHANGE, INC.	+3.22%	76.02B
LONDON STOCK EXCHANGE PLC	-3.45%	58.52B
NASDAQ, INC.	+5.78%	35.66B
B3 S.A. - BRASIL, BOLSA, BALCÃO	-24.81%	11.9B
EURONEXT N.V.	+6.42%	9.22B
MARKETAXESS HOLDINGS INC.	-30.26%	7.73B
TMX GROUP LIMITED	+12.61%	7.29B
SINGAPORE EXCHANGE LIMITED	-5.29%	7.35B
INVERFAL PERÚ S.A.A.	-1.37%	5.67B

Hong Kong Exchanges and Clearing Limited

Equities

388

HK0388045442

Financial & Commodity Market Operators

Hong Kong Exchanges and Clearing : BLUE APPLICATION FORM

Latest news about Hong Kong Exchanges and Clearing Limited

Chart Hong Kong Exchanges and Clearing Limited

Company Profile

Income Statement Evolution

Ratings for Hong Kong Exchanges and Clearing Limited

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Financial & Commodity Market Operators